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ABSTRACT 
Surface-immobilized adeno-associated virus nanoparticles for applications in controlled 
gene delivery and biosensing 
by 
Kellie Irene McConnell 
Adena-associated virus (AAV) is a 25 nm replication deficient DNA virus most commonly 
studied for human gene therapy applications. The work detailed in this thesis 
investigates the controlled delivery of AA V from surfaces for both transduction and 
biosensing applications. First, AAV was tested for compatibility with substrate-mediated 
gene delivery approaches. Two reverse transduction applications were investigated: 1) 
spatial localization of cells and virus vectors for tissue engineering applications and 2) 
live cell genetic microarrays. To drive the proper differentiation and assembly of cells 
within tissue engineering constructs, gene expression patterns may need to be tightly 
regulated. To localize adhesive proteins and AAV, polydimethylsiloxane stamps and 
protein adhesive alkanethiols were used. By adsorbing AAV onto adhesive proteins, 
including human fibronectin, laminin, collagen I, elastin and poly-1-lysine, both cell 
adhesion and gene delivery were localized to a defined pattern. Gene delivery was 
efficient on all protein surfaces, with higher expression observed on laminin surfaces. 
AAV was also patterned using a robotic spotter to create live cell genetic microarrays, 
creating localized cell islands expressing GFP. This potentially high-throughput 
technique could be extended to study complex genetic interactions within cells, such as 
stem cells or induced pluripotent stem cells. Additionally, AAV was explored as a 
biosensor by modifying virus output functionalities. Wild-type AAV2 externalizes an N-
terminus region containing a phospholipase A2 (PLA2) domain during intracellular 
processing, allowing the virus to escape the endosomal pathway and deliver genetic 
cargo. This externalization can be replicated outside of cells through heat treatment. 
AAV2-~PLA2-His was created by replacing the PLA2 domain with a nickel binding 
hexahistidine tag. This replacement allows heat-treated mutant virus to bind a nickel 
affinity column. Finally, directed evolution was used to 1) improve the ability of AAV to 
deliver genes into target cells or 2) alter AAV biosensor inputs. Virus libraries were 
created using error-prone polymerase chain reaction (EP-PCR) to introduce random 
amino acid modifications into the protein capsid. The error rate for these libraries was 
estimated to be between 5-7 errors per cap gene. Combining surface immobilization 
with directed evolution could allow for precise control of AA V for gene delivery and 
biosensing. 
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CHAPTER ONE 
Introduction 
1.1 Adena-associated virus 
Adena-associated virus (AAV) is a replication-deficient dependovirus that requires a co-
infection with adenovirus (Ad) or herpes virus for replication. AAV was first isolated as a 
contaminant in adenovirus stocks in the 1960s and the first AAV serotype 2 infectious 
clone was isolated in 1982.1·2 AAV has no known pathogenicity and it is estimated that 
90% of the human population is seropositive for AAV2.3 AAV is a small viral 
nanoparticle with a diameter of approximately 25 nm. The crystal structure of the virus 
was determined by Xie et al in 2002 (Figure 1.1 A). 4 AAV has a single-stranded DNA 
genome of -4.7 kb that consists of two open reading frames flanked by inverted terminal 
repeats (ITRs) (Figure 1.1 B). The two open reading frames of the genome encode for 
AAV's two genes - rep and cap. The rep gene codes for four non-structural proteins 
(Rep78, Rep68, Rep52, and Rep40) that aid in the replication of the virus. The cap gene 
codes for three structural proteins and one non-structural protein involved in virus 
assembly5 through alternative splicing and alternative start codon usage. VP1, VP2, and 
VP3 are contained in the capsid at a 1 :1 :10 ratio, respectively. The virus capsid is 
composed of 60 subunits and forms through self-assembly. 
2 
A 
B 
Figure 1.1. Adeno-associated virus. (A) Crystal Structure of AAV2 (Adapted from Xie 
et al) .4 (B) Schematic of AAV2 genome, composed of rep and cap genes flanked by 
ITRs. 
To date, 12 serotypes of AAV have been isolated.6 Within these serotypes, some 
capsid regions are conserved and others are notably different. It is known that 
serotypes have different tropisms and readily transduce different tissues within the body. 
For example, AAV2 is known to transduce kidney cells readily and AAV4 is known to 
transduce the central nervous system.7 These differences in tropisms are mainly due to 
serotypes binding to different cell surface receptors. AAV2, the most commonly studied 
serotype, primarily binds heparan sulfate proteoglycans (HSPGs) .8 In contrast, AAV1 
and AAV6 both bind sialic acid. 9 In addition to binding tropism, it has also been shown 
that different serotypes have varying uncoating rates. 10 
3 
1.2 Overview of thesis 
While AAV has most commonly been investigated for human gene therapy, this thesis 
explores the use of AAV for surface-immobilization applications. AAV is a versatile 
vector capable of delivering genetic cargo to a variety of cell types, both dividing and 
non-dividing. However, for virus performance to be optimal, we must be able to control 
the transduction profiles of the virus. By combining surface-immobilization with 
regulation of virus binding and conformational changes, we may be able to harness AAV 
delivery for tight control of virus activity. Surface-immobilization allows for spatial control 
of vectors for both gene expression and biosensing. Further optimization of virus 
performance could be achieved through combinatorial directed evolution approaches. 
An overview of this thesis is outlined in Figure 1.2. We have patterned AAV through 1) 
microcontact printing using polydimethylsiloxane (PDMS) stamps and alkanethiol 
solutions and 2) a robotic microarray spotter. Microarray deposition was explored to 
pattern virus nanoparticles for both live cell genetic microarrays and biosensing. To use 
AAV as a potential biosensor, we have modified the virus output to allow for the 
externalization of a nickel ion binding hexahistidine tag. Modification of the virus for both 
optimal gene delivery and novel biosensing properties was explored through the creation 
of directed evolution libraries. 
i A 
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Figure 1.2. Schematic overview of thesis. Immobilization of AAV onto surfaces was 
investigated for tissue engineering and microarray applications. Directed evolution 
studies were initiated to tailor AAV for novel gene delivery and biosensing applications. 
1.3 Patterned gene delivery for tissue engineering 
The creation of more native-like tissues in vitro may hinge on the ability to create highly 
localized gene delivery profiles. 11 The use of AAV for gene delivery in tissue 
engineering/regenerative medicine applications is a highly attractive choice due to its 
higher safety profile and ease of manipulation compared to other viral gene delivery 
systems, and the numerous methods to achieve target cell specificity and efficiency. To 
begin to address this tissue engineering hurdle, we have used polydimethylsiloxane 
(PDMS) stamps to create localized regions of protein-adhesive alkanethiols on gold 
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substrates. Alkanethiols have been extensively used to localize protein and cells. 12.14 
These long carbon chains have a sulfur group at one end that can bind to a gold 
substrate, forming a self-assembled monolayer (SAM) with an exposed functional group. 
These patterns are backfilled with oligo(ethylene glycol) (-OEG) terminated alkanethiols, 
creating a protein resistant background. Initial studies, detailed in Chapter 2, explored 
the use of -CH3, -COOH, -NH2, -OH surface chemistries to localize both human 
fibronectin (HFN) and AAV2-GFP (delivering the gene for GFP). Alkanethiols were 
patterned using PDMS stamps displaying 500 micron circular features. 
We have demonstrated that this technique can be successfully applied to the localization 
of HeLa cells. Cells were successfully localized onto three SAM surfaces with minimal 
adhesion of cells to the passivated background. Additionally, GFP expression was 
observed on all surface chemistries. Most interestingly, we observed that the presence 
of a protein mediating layer for AAV adsorption allowed for increased gene expression, 
in comparison to direct adsorption of virus onto SA Ms. 
Given the positive results observed with HFN, in Chapter 3 we explored a variety of 
additional adhesive proteins, including laminin, elastin, poly-1-lysine (PLL) and collagen I. 
While all four additional proteins are compatible with our patterned reverse transduction 
platform, we observed that the most efficient gene delivery was observed on laminin 
surfaces. As it was determined that transcriptional activity was not the reason for the 
increase in gene expression, additional methods are being used to study the interaction 
between adhesive proteins and AAV. 
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1.4 Live cell genetic microarrays 
High-throughput manipulation of gene expression may hold the power to elucidating the 
complex interactions responsible for the differentiation of stem cells and the 
development of induced pluripotent stem cells. Increased interest in tissue engineering 
and stem cell lineage development has introduced the need for a high-throughput 
method for studying the effects of multiple combinations of cells, growth factors, and 
extracellular matrix components found in stem cell niches. 15'16 Surrounding niche cells 
have been identified as having particular importance in supporting proper 
differentiation.16 However, the exact nature of this interaction is not known. In the past, 
many classical developmental biology studies have relied on available model organisms 
such as Drosophila and Caenorhabditis elegans. Understanding the functionality of 
stem cells will rely on combining knowledge of different interactions within a niche. 15 In 
addition to using these important in vivo models, valuable information can be obtained by 
performing high-throughput gene expression screens on mammalian cells. The ability 
to perform a high number of screens with as few cells as possible is valuable because 
primary cells required for studies can be difficult to accumulate in large quantities. 17 
Moreover, high-throughput screens allow for the delivery of many distinct gene 
combinations to populations of cells, making this type of experiment a valuable 
technique for studying downstream cellular effects. In response to the need for patterned 
gene delivery, both viral18· 19 and nonviral20-22 gene delivery methods have been 
employed to develop an efficient screening technology. In this thesis we have 
investigated the use of AAV for this technology. AAV offers a number of advantages 
compared to other virus systems, as AAV is considered to be safer and capable of 
relatively facile modification to increase gene delivery efficiency and specificity. 
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In Chapter 4, we explored the use of AAV2 as a gene delivery vector for live cell genetic 
microarrays. A number of substrates and conditions were tested, and we have 
determined that nitrocellulose coatings are capable of localizing high levels of non-
denatured recombinant AAV when deposited using a robotic spotter. By backfilling 
these substrates with a blocking agent, we have been able to create localized islands of 
GFP expressing cells. 
1.5 AAV as a potential biosensor 
During its natural life cycle, AAV is capable of responding to stimuli located on and within 
the cell. First, AAV bind ligands on the outside of the cell to initiate cellular infection. For 
example, AAV2 binds heparan sulfate proteoglycans and AAV1 and AAV6 bind to sialic 
acid. Post cell binding, the virus is trafficked through the endosomal pathway. Within 
endosomes, it is proposed that a combination of pH and additional unidentified factors 
elicits the externalization of a previously internalized N-terminus domain.23· 24 This region 
contains a phospholipase A2 (PLA2) domain, facilitating the release of the virus into the 
cytoplasm24 and eventual transport of DNA to the nucleus. 
In Chapter 5 we have altered this virus "output" by replacing the PLA2 domain with a 
nickel binding hexahistidine tag, creating a mutant virus (AAV2-LlP.His). In addition to 
intracellular factors, the virus N-terminus externalization can be induced outside of the 
cell by heating the virus to 60-65°C. By heating AAV2-LlP.His to 63°C, we have shown 
that we can isolate activated virus particles using a nickel affinity column. Ultimately, 
we would like to modify the virus input to detect different stimuli. Virus nanoparticles 
would be modified such that their input would be a desired stimulus (likely a protein or 
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small molecule of interest) and their output would be a domain that we could efficiently 
detect (fluorescent particle, enzymatic domain, detectable tag). 
1.6 Directed evolution of AAV 
A significant amount of work has been done to retarget AAV to increase specificity and 
transduction efficiency for a desired cell type. The first studies toward retargeting were 
conducted using rational approaches, attaching antibodies to the capsid to alter virus 
tropism.25 Later, rationally determined peptides were added within regions of the capsid 
that were determined to tolerate small insertions. Generally, these small peptides were 
inserted to retarget the virus to a known receptor of interest. One such early approach 
was the insertion of an RGD (arginine-glycine-aspartic acid) motif, known to bind cellular 
integrins. 26 
In contrast, directed evolution allows us to create large, combinatorial libraries and select 
for variants with advantageous mutations. To alter the binding properties of AAV, 
several directed evolution methods, including error-prone polymerase chain reaction 
(EP-PCR),27• 28 peptide display,29· 30 transposon mutagenesis,31 and DNA shuffling32.34 
have been used to optimize AAV gene delivery. Successful mutants have been found to 
evade serum neutralization, infect coronary artery cells, infect brain cells, and infect 
glioma cells, among other applications.29"36 Directed evolution libraries are generated by 
creating large (>1 06) pools of mutants and selecting for a clone with the desired 
characteristics. An overview of this process for EP-PCR mutagenesis is shown in Figure 
1.3. 
(1) Isolation of cap gene 
(2) Random mutagenesis 
through EP-PCR 
(3) Re-clone genome to Q~:t:::J'..:l~~Q Q~:::s;;;;:~ 
form plasmid library 0 0 o~~::::X:::J-i 
t 
t 
(6) Analyze mutants, 
re-clone for repeated 
mutagenesis or selection 
(5) Select for mutants with 
desired properties 
(4) Package and purify 
virus library 
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Figure 1.3. Overview of directed evolution process. Large pools of mutant virus are 
generated using EP-PCR. Selection strategies aim to enrich a pool of mutant virus 
capable of fulfilling a specified need. 
Directed evolution allows us to potentially fine-tune the characteristics of AAV that are 
critical for optimal performance in our applications detailed in Chapters 2-5. In Chapter 6 
we have created two AAV2-based libraries using EP-PCR. One library, based on the 
wild-type AAV2 genome, contained 5.2 errors per cap gene, and has been used to 
isolate a pool of mutants with increased transduction efficiency for an ovarian cancer cell 
line. A second library, based on AAV2-f\P.His, was generated with an error rate of 7.3 
errors per cap gene. Overall, we show increased efficiency in HeyAB ovarian cancer cell 
transduction as well as slight modifications to the temperature responsive properties of 
our f\P.His virus. Additional enrichment and mutagenesis should be performed to isolate 
the "fittest" mutants from these pools. Further studies are needed to fully characterize 
these mutants and understand the effects that individual mutations have on the change 
of function observed. By combining spatial localization with modifications through 
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directed evolution, we can potentially tightly control virus delivery for gene expression 
and biosensing. 
CHAPTER TWO 
Microcontact printing for co-patterning cells and viruses for spatially 
controlled substrate-mediated gene delivery 
2.1 Acknowledgements 
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I would like to thank Dr. John Slater and Dr. Jennifer West for their collaboration on this 
work. PDMS stamps were created by Jaewon Park in Dr. Arum Han's lab at Texas A&M 
University. The work presented in this chapter is a modified version of a manuscript 
accepted for publication in Soft Matter. 
2.2 Introduction 
A significant hurdle in tissue engineering and regenerative medicine is the difficulty in 
achieving spatially organized tissue structures. 11 To drive the proper differentiation and 
assembly of cells, gene expression patterns may need to be tightly regulated. This may 
entail the expression of certain genes, involved in tissue genesis or repair, to be 
upregulated or downregulated in a spatially dependent manner. Among the advances in 
this field has been the incorporation of gene delivery agents, desired to guide the 
development of more native-like in vitro tissues. Pioneering methods of incorporating 
gene delivery in tissue engineering constructs involved the inclusion of plasmid DNA in 
polymeric matrices.21 Since that time multiple groups have worked to create methods to 
deliver genetic material for tissue engineering applications, based on either the delivery 
of plasmid DNA or on viral transduction. 19· 22· 37-39 
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Viral gene delivery is a promising alternative to the use of plasmid DNA for substrate-
mediated gene delivery, also called reverse transfection or reverse transduction when 
non-viral or viral vectors are used, respectively. Viral particles can be easily modified to 
deliver a desired genetic cargo of either an overexpression or shRNA cassette. In recent 
years, several viruses have been used to control the delivery of genes for a variety of 
substrate-mediated applications, including targeted gene delivery for wound healing, 
bone remodeling, and prevention of restenosis. 40-42 Lentiviral and adenoviral vectors 
have been used to create cellular microarrays for upregulation or downregulation of 
genes of interest. 18· 43· 44 Pirone et al implemented microcontact techniques for 
patterning adenovirus onto plastic. 19 Retroviruses have also been immobilized using 
alkanethiol self-assembled monolayers (SAMs), either through direct adsorption or 
through the use of a protein mediating layer.37 Previous studies have shown that 
retrovirus is capable of interacting with extracellular matrix proteins, including fibronectin, 
to increase gene delivery efficiency in target cell types.45 
We set out to build upon these previous studies to advance the technology to the next 
level. First, we envisioned creating a platform where both viral gene delivery vectors and 
adhesive proteins can be co-patterned to control both cellular attachment and gene 
expression. This can ultimately enable us to modulate the virus pattern underneath the 
cell pattern, resulting in the creation of distinct regions of gene expression within the cell 
pattern. Furthermore, we desired to use a gene delivery vector that can be easily tailored 
to deliver genes into target cells with high efficiency. AAV is a relatively simple virus to 
modify, encoding only two viral genes: rep and cap. Modification of the cap gene can 
substantially improve the specificity and efficiency of AAV-mediated gene delivery. 
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Numerous advances in AAV targeting have been made recently (reviewed by Schaffer et 
al46), providing us with many potential options to enhance the selectivity of the vectors 
for specific cells. Eventually, by exploiting different combinations of virus patterns, cell 
patterns, transgenes, cell types, and AAV capsids (with different capsids targeting 
different cell types), we may be able to mimic the structure and function of highly 
complex tissues. 
AAV is a small, 25 nm diameter replication deficient parvovirus that is being investigated 
intensively in 75 gene therapy clinical trials worldwide. AAV is considered to be one of 
the safest viral vectors for gene delivery, owing to several properties. AAV does not 
mediate insertional oncogenesis, which has been observed for retrovirus vectors, 47 and 
immunogenicity against the virus is substantially less than that of adenovirus vectors.48 
AAV is a non-enveloped virus composed of a protein shell encapsidating a 4.7kb single 
stranded DNA genome. As mentioned above, the simple viral genome contains only two 
genes: rep, coding for non-structural replication proteins, and cap, coding for three 
proteins that self-assemble to form the viral capsid and a fourth protein that aids in this 
assembly.5 A number of naturally occurring serotypes with diverse tropism and 
transduction profiles have been isolated.7 The most commonly used serotype is AAV2, 
known to bind negatively charged heparin.49 The crystal structure of this well-studied 
virus has been resolved. 4 In addition to the various serotypes, there are a variety of 
methods to alter the tropism of the virus in order to increase the gene delivery efficiency 
in a target cell population. These methods range from rationally inserting a targeting 
moiety into the capsid to using directed evolution to isolate an improved mutant out of a 
large pool of variants. 26• 27• 29• 34 Lastly, AA V can be altered to deliver various genetic 
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cargo, including overexpression cassettes as well as shRNA.50· 51 Collectively, the use of 
AAV for gene delivery in tissue engineering/regenerative medicine applications is a 
highly attractive choice due to its higher safety profile and ease of manipulation 
compared to other viral gene delivery systems, and the numerous methods to achieve 
target cell specificity and efficiency. 
To spatially localize AAV2 vectors and cellular adhesion, we used microcontact printing 
of alkanethiols to create patterned self-assembled monolayers (SAMs). Microcontact 
printing techniques use elastomeric stamps with micron scale features to print molecules 
onto a surface.52 For this work, we stamped alkanethiols onto gold-coated glass 
covers lips (Figure 2.1 ). Alkanethiol molecules are long carbon chains, with a functional 
group on one end and a gold binding sulfur molecule on the other end. Through Vander 
Waals forces, the chains self-assemble into a monolayer of 2-3 nm in height at a 30° 
angle.52 These SAMs form patterned features and can have either protein adhesive or 
protein resistive properties. Through this method, we are able to directly control the 
spatial localization of the virus, as opposed to adding it in a bulk solution and exposing 
all cells to the same gene delivery agent. In this work, we patterned chemistries that are 
potentially adhesive to both AA V2 and cellular attachment proteins. 
Ink stamp with 2mM 
alkanethiol solution 
Image cells 
DIC: cell adhesion 
Fluorescence: GFP expression 
Place stamp on gold coated 
coversl ip, forming SAM 
Seed Hela cells 
1 00 cells/mm2 
Backfill with - OEG terminated 
alkanethiol solution 
I ' I ! \ \ 
HFN, AAV2-
GFP or both 
Incubate with protein 
HFN: 25 tQ/mL, 30 min 
AAV2-GFP: 6.5e11 genomes/ml , 20 min 
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Figure 2.1. Overview of microcontact printing process. PDMS stamps were inked 
with one of four protein adhesive alkanethiol solutions and placed onto a gold coated 
coverslip. Samples were backfilled with -OEG and incubated with HFN and AAV2. 
Samples were seeded with Hela cells and imaged 72 h later. 
We have developed a patterning platform to combine both the patterning of cells as well 
as AAV2 for gene delivery. Microcontact printing and a variety of alkanethiol surface 
chemistries have been used to identify a SAM that allows for both the attachment of cell 
adhesive proteins (human fibronectin, HFN) and reversible immobilization of AAV2. 
Relative attachment of both fibronectin and AAV2 was visualized and quantified using 
immunostaining. To test cell adhesion and the efficiency of viral transduction in this 
system, we used a green fluorescent protein (GFP) reporter gene and Hela cervical 
cancer cells, which are known to be highly permissive to AAV2 transduction. 53 At various 
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times post cell seeding, patterns were analyzed for both cellular attachment as well as 
efficiency of gene delivery. 
2.3 Materials and Methods 
Virus preparation. AAV2 was prepared as described previously.54 Briefly, 293T cells 
and a triple transfection method were used to produce recombinant AAV2-GFP (AAV2 
capsid with a green fluorescent protein (GFP) cassette under the cytomegalovirus (CMV) 
promoter). Cells were lysed 72 h post-transfection and virus was purified using 
ultracentrifugation and an iodixanol step gradient. Virus used for these studies remained 
in a solution of 40% iodixanol. Viral genomic titers were determined using quantitative 
polymerase chain reaction (QPCR) with primers against the CMV promoter. Virus used 
in this study was determined to have a concentration of 6.5e11 vector genomes/ml. 
PDMS stamp and coverslip preparation. Polydimethylsiloxane (PDMS) stamps were 
prepared by cast molding PDMS from a mold master that was fabricated by a 
photolithography process. First, a photoresist (SU-8™, Microchem, Inc., Newton, MA) 
layer was spin-coated on a 3-inch silicon wafer (SQI, Inc., Santa Clara, CA) and 
selectively exposed to UV light to transfer stamp patterns on the photomask to the SU-
a™ layer. It was then immersed in photoresist developer (Thinner P, Microchem, Inc., 
Newton, MA) and rinsed with isopropyl alcohol (IPA). To facilitate the release of PDMS 
stamps from the master after the cast molding process, the mold master was vapor-
coated with (tridecafluoro-1, 1 ,2,2-tetrahydrooctyl) trichlorosilane (United Chemical 
Technologies, Inc., Bristol, PA) for 10 min and briefly rinsed with IPA. The stamps were 
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replicated by pouring PDMS pre-polymer (1 0:1 mixture, Sylgard® 184, Dow Corning, 
Inc., Midland, Ml) on the mold master, followed by degassing inside a vacuum 
connected desiccator for 15-20 min to remove air bubbles and to completely fill the 
micropatterns with the PDMS. The degassed PDMS device was placed inside a leveled 
85°C oven for 1 h for polymerization. The fully polymerized PDMS device was then 
peeled off from the mold master and used as a microcontact printing stamp. 
PDMS stamps presenting 500 micron diameter circles with a 1.2 mm pitch were cleaned 
by sonication in 100% ethanol. 35 mm diameter gold-coated glass covers lips (1 00 A 
gold over 20 A titanium, Platypus, Madison WI) were cleaned in dilute TL 1 solution 
(6:1 :1 H20:NH40H:H202) for 1 min at 80°C, rinsed twice in Millipore purified water 
(MPH20), and dried with ultrapure nitrogen (N2). 
Surface functionalization. Alkanethiol solutions were diluted to 2 mM in 1 00% ethanol. 
Stamps were inked with either a -CH3 (1-hexadecanethiol), -COOH (16-
mercaptohexadecanoic acid), -NH2 (11-amino-1-undecanethiol hydrochloride), or -OH 
(11-mercapto-1-undecanol) terminated alkanethiol, all from Sigma Aldrich (St. Louis, 
MO). Stamps were dried with N2, placed on a gold coverslip for 20 sec, and gently 
removed. After printing, coverslips were incubated with 2 mM oligo(ethylene glycol) (-
OEG) terminated alkanethiol (HSC11 -EG6, Prochimia, Poland) for 1 h. Samples were 
rinsed twice with 100% ethanol and dried with N2. 
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Protein attachment. Functionalized coverslips were incubated with 1 ml human 
fibronectin (HFN, Sigma Aldrich) warmed to 37°C at a concentration of 25 mg/ml in 
phosphate buffered saline (pH 7.0, PBS) for 20 min at room temperature and rinsed 
dropwise with PBS. To adsorb virus, functionalized covers lips were incubated with 0. 75 
ml AAV2-GFP at a concentration of 6.5e11 vector genomes/ml in 40% iodixanol for 30 
min at room temperature and rinsed dropwise with PBS. 
lmmunostaining. HFN and/or AAV2 functionalized samples were blocked with 1% BSA 
in PBS for 1 h followed by gentle dropwise rinsing with PBS. HFN patterns were 
incubated with sheep anti-FN primary antibody (Abeam, Cambridge, MA) at 0.01 mg/ml 
overnight at 4°C, rinsed with PBS, and exposed to donkey anti-sheep AlexaFiuor 633 
(AF633) conjugated antibody (Invitrogen, Carlsbad CA) at 0.02 mg/ml for 1 h at room 
temperature. Samples were rinsed dropwise with PBS, sterile water, and allowed to air 
dry. AAV2 patterns were incubated with A20 antibody (mouse anti-AAV2 capsid, 
American Research Products, Belmont MA) at a concentration of 0.25 mg/ml overnight 
at 4°C, rinsed with PBS, and exposed to goat-anti-mouse AlexaFiuor 532 (AF532) 
conjugated antibody (Invitrogen) at a concentration of 10 mg/ml for 1 h at room 
temperature. Samples were rinsed dropwise with PBS and sterile water and allowed to 
air dry. 
Cell studies. Hela cells were seeded on functionalized surfaces in 60 mm tissue culture 
dishes at a density of 100 cells/mm2. Cells were cultured in Dulbecco's Modified Eagle 
Medium (Invitrogen), supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin (Invitrogen). Cells were maintained at 37 oc with 5% C02. 
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Imaging and image analysis. Images were acquired using a Zeiss 5 LIVE confocal 
microscope (Carl Zeiss, Munich, Germany). Images within a given sample set (i.e. 
AAV2 adsorption, HFN adsorption, cell fluorescence) were acquired under identical 
conditions. GFP images were obtained using a 489 nm excitation at 1.8% power and 
data was collected for 2 ms pixel dwell time with a bandpass filter between 500-525 nm. 
Virus immunostaining images were collected using a 532 nm excitation at 50% power 
and data was collected for 2 ms pixel dwell time using a bandpass filter between 550-
600 nm. HFN immunostaining images were collected using a 635 nm laser at 20% 
power and data was collected for 2 ms using a longpass 650 nm filter. Confocal control 
experiments were done to ensure no crosstalk between channels. To quantitatively 
compare the ability of each SAM to adsorb HFN and AAV2, the integrated densities of 
15 spots (5 spots from 3 different stamps) were measured with lmageJ (NIH, Bethesda 
MD). For transduction studies, 5 fluorescence and differential interference contrast 
(DIG) images were taken at each time point. Integrated densities of fluorescence 
images were taken and values were normalized to that of -CH3 samples at the 24 h time 
point. Data is given as mean and standard error of the mean. JMP 9 software was 
used to determine statistical significance (p<0.05) using ANOVA and Tukey's HSD for 
post-hoc pair comparisons. 
2.4 Results 
-CH3 and -NH2 surfaces most efficiently immobilize HFN. The ability to spatially 
control cell attachment to surfaces is an integral component in the creation of patterned 
cell constructs. We implemented microcontact printing to create 500 pm diameter 
circular patterns of one alkanethiol SAM, either a -CH3, -COOH, -NH2, or -OH terminated 
20 
alkanethiol, surrounded by a biologically inert oligo(ethylene glycol) (-OEG) terminated 
SAM. Due to the passive nature of the -OEG SAM, HFN preferentially adsorbs to the 
circular patterns leaving the surrounding background free of protein. Using these 
alkanethiol molecules, we are able to create hydrophobic (-CH3), hydrophilic (-OH), 
negatively charged (-COOH), and positively charged (-NH2) surfaces. To study the 
efficacy of each surface chemistry (-CH3. -COOH, -NH2, and -OH) to mediate HFN 
binding and hence cell attachment, we used immunostaining and fluorescence 
microscopy to compare the amount of HFN that adsorbs to each SAM. The patterned 
surfaces were exposed to HFN, fluorescently immunolabeled, imaged under identical 
conditions, and the fluorescence integrated density of the patterned regions was 
measured. The hydrophobic -CH3 SAM adsorbs the highest amount of HFN, displays 
uniform surface coverage (Figure 2.2A, E) and was, therefore, used to normalize the 
integrated density values of the remaining surfaces. The -NH2 patterned SAM shows a 
similar level of high and uniform attachment (Figure 2.2C). The -COOH SAM results in 
immobilization of less HFN, 47% as compared to the -CH3 SAM, and the patterns contain 
noticeable defects resulting in non-uniform HFN coverage (Figure 2.28 & E). In these 
-COOH images, it is interesting to note that the defects appear as though the protein 
layer is peeling away. We believe that this happens because of the ten washing steps 
involved with immunostaining and they are seen in additional immunostaining images 
(Figure 2.38 and 2.48). In the later studies where cells are seeded on the surfaces, we 
do not perform these washing steps. The -OH pattern shows minimal HFN attachment 
and adsorbs only 23% of the HFN compared to the -CH3 SAM (Figure 2.20, E). Previous 
studies that used non-patterned alkanethiol SAMs with varying functional groups showed 
similar results in protein adsorption and observed both surface wettability- and charge-
dependent protein adsorption behavior.55 The finding that HFN adsorbs to all of the 
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SAMs tested indicates the potential of each SAM to support cell attachment. However, 
SAM-dependent differences in the amount of HFN adsorbed and in the uniformity of 
coverage could lead to differences in initial cell attachment, cellular proliferation, AAV2 
adsorption, AAV2 transduction, and ultimately gene expression. 
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Figure 2.2. Adsorption of HFN to micropatterned SAMs with varying functional 
groups. -CH3 (A), -COOH (B) , -NH2 (C), and -OH (D) terminated alkanethiol SAMs were 
microcontact printed in 500 pm diameter circles, backfilled with an -OEG terminated 
SAM, exposed to HFN, fluorescently immunostained, imaged, and the integrated density 
of the patterns measured (E). The -CH3 and -NH2 terminated alkanethiol patterns (A&C) 
show a similar amount of adsorbed HFN. The -COOH (B) and -OH (D) surfaces show 
significantly less adsorption. Scale bar is 100 ~m. (E) Relative amounts of HFN 
adsorbed to the various SAMs were determined by comparing the integrated densities 
(as quantified with lmageJ) of the circular patterns. Values were normalized to that of the 
-CH3 spots. Error bars indicate standard error of the mean. Statistical significance 
(p<0.05) is indicated with * for comparison against -COOH and # against -OH. 
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-CH3 surfaces most efficiently immobilize AA V2. Similar to how spatial control of HFN 
adsorption is important for effective cell patterning, spatial control of AAV2 vector 
adsorption is crucial in spatial regulation of gene expression. To determine the efficacy 
of the four previously tested surfaces on AAV2 attachment, we repeated the adsorption 
analysis procedure used to quantify HFN adsorption. Micropatterned surfaces of the 
various functional group SAMs were exposed to AAV2, fluorescently immunolabeled, 
imaged under identical conditions, and the integrated densities measured. The various 
alkanethiol terminal groups yield different AAV2 immobilization patterns as well as 
variable amounts of virus attachment (Figure 2.3). As with HFN attachment, the -CH3 
surface results in the highest adsorption of AAV2 with the most uniform coverage (Figure 
2.3A, E). The patterned -COOH, -NH2, and -OH SAMs result in heterogeneous, non-
uniform, punctate AAV2 coverage (Figure 2.38-D) with each SAM immobilizing 43%, 
46%, and 41% of the amount adsorbed to the -CH3 SAM, respectively (Figure 2.3E). 
Overall, it appears that HFN and AAV2 both have similarly high affinities for the 
hydrophobic -CH3 patterned SAMs. Interestingly, surface charge seems to have little 
influence here on AAV2 adsorption as the -COOH and -NH2 have similar levels of 
attachment. Furthermore, the antibody used in the immunostaining detects intact virus 
capsids only. Thus, the immobilized virus appears structurally intact and not denatured. 
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Figure 2.3. Adsorption of AAV2 to micropatterned SAMs with varying functional 
groups. -CH3 (A), -COOH (B), -NH2 (C), and -OH (D) terminated alkanethiol SAMs were 
microcontact printed in 500 J.lm diameter circles, backfilled with an -OEG terminated 
SAM, exposed to AAV2, fluorescently immunolabeled, imaged, and the integrated 
density of the patterns measured (E). The -CH3 terminated alkanethiol patterns (a) 
adsorb more AAV2 than -COOH (B), -NH2 (C) or -OH (D) terminated alkanethiols. Scale 
bar is 100 ~m. (E) Relative amounts of AAV2 adsorbed to the various SAMs were 
determined by comparing the integrated densities (as quantified with lmageJ) of the 
circular patterns. Values were normalized to that of the -CH3 spots. Error bars indicate 
standard error of the mean. Statistical significance (p<0.05) is indicated with * for 
comparison against -COOH, + against -NH2, and #against -OH. 
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-CH3 and -NH2 surfaces most efficiently immobilize AA V2 and HFN. Patterned gene 
expression requires the attachment of both cell adhesive protein (HFN) and gene 
delivery vectors (AAV2) to the same micropatterned region. To achieve this, we 
patterned HFN and viral vectors together on one surface. For our studies, 
micropatterned SAM surfaces were exposed to HFN followed by incubation with AAV2. 
We rationalized that immobilizing HFN first will prevent this layer from sterically impeding 
the virus from gaining access to cells. The four different functional group SAMs were 
investigated and the samples were immunostained, imaged, and analyzed as described 
above. In this co-patterned case, the -CHs and -NH2 (Figure 2.4A and 2.4C) spots show 
qualitatively high, homogenous levels of attachment. Again, -COOH and -OH patterns 
display incomplete pattern coverage (Figure 2.48 and 2.40). As with Figure 2.28, we 
see a similar staining pattern for the -COOH surface that suggests washing away of the 
protein layer. The image shown in Figure 2.48 is one example from the images taken, 
all of which showed a similar phenomenon. Quantitative measurements show that the 
-CH3 and -NH2 spots have statistically similar levels of AAV2 adsorption while the -
COOH (42%) and -OH (18%) spots show significantly less (Figure 2.4E). Since 
adsorption of both HFN and AAV is important for the viability of this technique, these 
qualitative and quantitative results for all surfaces suggest that AAV2 can successfully 
attach to a layer of HFN. In particular, homogenous coverage of AAV2 on the HFN pre-
incubated -CH3 and -NH2 SAMs suggests that these surfaces will be particularly effective 
in supporting viral transduction, as seen previously with retrovirus.37 
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Figure 2.4. Adsorption of AAV2 to pre-adsorbed HFN on micropatterned SAMs 
with varying functional groups. -CH3 (A), -COOH (B) , -NH2 (C) , and -OH (D) 
terminated alkanethiol SAMs were microcontact printed in 500 Jlm diameter circles, 
backfilled with an -OEG terminated SAM. Samples were pre-incubated with HFN and 
then exposed to AAV2, fluorescently immunolabeled, imaged , and the integrated density 
of the patterns measured (E). Images are pseudocolored for visualization of overlay. 
The left column shows HFN staining , the middle column shows AAV2 staining , and the 
right column is an overlay of the two channels. The -CH3 and -NH2 terminated pre-
incubated patterns (A&C) adsorb more AAV2 than -COOH (B) or -OH (D) terminated 
alkanethiols. Scale bar is 100 ~m. (E) Relative amounts of AAV2 adsorbed to the various 
SAMs were determined by comparing the integrated densities (as quantified with 
lmageJ) of the circular patterns. Values were normalized to that of the -CH3 spots. Error 
bars indicate standard error of the mean. Statistical significance (p<0.05) is indicated 
with *for comparison against -COOH and #against -OH. 
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-CH3, -COOH, and -NH2 surfaces support cell adhesion and efficient gene delivery. 
The goal of this platform technology is to precisely pattern cells of interest and deliver 
desired genes via immobilized viral vectors. To determine the efficacy of both of these 
goals, we conducted cell studies using Hela cells as a model. Cells were added to HFN 
and AAV2 co-patterned substrates to determine cell attachment and transduction. For 
the construct to be maximally successful, the pattern should be uniformly covered with 
cells and all cells should be expressing the virus encoded transgene, GFP. Alkanethiol 
patterns were incubated with HFN, then AAV2-GFP, and finally seeded with Hela cells 
at a density of 100 cells/mm2. Samples were imaged at 24, 48, and 72 h post-seeding 
and cell coverage and GFP expression were qualitatively observed. Minimal 
background cell attachment is seen in each case, indicating that the -OEG terminated 
alkanethiol surfaces provide an effective block to protein and cell attachment (Figure 
2.5). Three surfaces, -CH3, -COOH, and -NH2 (Figure 2.5A-C), yield homogenous 
coverage of cells throughout the pattern. The -COOH surface may better retain the 
protein layer in this experiment, in comparison to immunostaining studies (Figures 2.2& 
2.4), since we do not perform the ten washing steps when we seed cells. Cell 
attachment on the -OH patterned surface yields incomplete spot coverage (Figure 2.50). 
The viral vectors immobilized on the surfaces retain their infectivity, as seen by the 
robust GFP expression in the patterned cells for all four surfaces. This implies that 
vectors are able to efficiently release from the surfaces and are not denatured by 
immobilization. 
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Figure 2.5. Attachment and transduction of Hela cells. Gold coated coverslips were 
patterned with -CH3, -COOH, -NH2, or -OH terminated alkanethiols in a spot pattern (A-
D). Patterns were pre-incubated with HFN and then exposed to AAV2. Samples were 
rinsed and seeded with He La cells at a density of 100 cells/mm2. Cells were imaged 
under DIC conditions to evaluate cell deposition (left image) and fluorescence to 
evaluate GFP expression (right image). Images shown are at 72 h time point. Scale bar 
is 100 ~-tm. Fluorescence intensity was measured at 24, 48, and 72 h post-cell seeding 
(E). Values were normalized to the -CH3 spot intensity at 24 h. Error bars indicate 
standard error of the mean. At 24 h, -CH3 is significantly higher (*) than the other three 
surfaces (p<O.OS). At 48 h, all surfaces are similar. At 72 h, statistical significance 
(p<O.OS) is indicated with #for comparison against -OH. 
At each time point, gene expression was quantified. Fluorescence for each time point 
was normalized to that of the -CH3 samples at the 24 h time point. GFP expression 
increases over time for all four SAMs (Figure 2.5e). At the 24 h time point, GFP 
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expression is significantly higher for -CH3 compared to the other 3 surfaces. All samples 
are similar at the 48 h time point. By the final 72 h time point, the -COOH spots have 
significantly higher overall GFP expression only when compared to the -OH surface. The 
-OH surface has a lower cell density compared to the other surfaces (73% average cell 
coverage). If the -CH3 normalized integrated density at 72 h is adjusted to match the cell 
density of the -OH surface, the density will drop to 2.3 - a value lower than the -OH 
integrated density of 2.6. This result suggests that cells on the -OH pattern have a 
slightly higher fluorescence per cell. 
2.5 Discussion 
The ability to localize cells and deliver genes efficiently is a favorable outcome for this 
study. For three of the chemistries, pattern features are completely covered with cells, 
with almost no background or extension off the spots. As expected from immunostaining 
data, both the -CH3 and -NH2 surfaces support cell attachment and efficient gene 
delivery. However, the same cellular result is also true for the -COOH SAMs, a result 
that seems inconsistent with immunostaining data. From analyzing the images in Figure 
2.28 and Figure 2.48, we believe that the flaws in these patterns are due to the removal 
of protein during the successive wash steps in immunostaining. For cell studies, fewer 
washes are conducted, likely resulting in more protein remaining attached to the surface. 
Additionally, it is possible that even on surfaces adsorbing significantly less AAV 
(-COOH and -OH), there is still enough virus to transduce the overlying cells. If we 
assume that there is a complete monolayer of viral vectors on the HFN coated -CH3 
surfaces, this would equate to a multiplicity of infection (MOl) of 4x1 08 viral vectors per 
cell, based on the average cell density. Even with the lower amount of viral vectors seen 
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on other surfaces, this would still lead to an MOl of 8x1 05 and 4x1 05 viruses per cell on 
the -COOH and -OH SAMs, respectively. These MOis are substantially large and could 
lead to the high levels of expression observed on these surfaces. More quantitative 
analytical methods are currently under investigation to validate these hypotheses. 
Overall, gene expression is robust on all four SAMs, indicating that there are a variety of 
surface chemistries that can support this technique. 
Cell transduction studies show high transduction of the patterned cell population. By 
transducing a large percentage of cells, we have the ability to efficiently modulate the 
behavior of the whole cell population. Ultimately, this process can be extended to the 
creation of more complex tissues using various cells, adhesive proteins, and gene 
delivery cassettes. Since cellular attachment and viral transduction are compatible with -
CH3, -NH2, and -COOH surfaces, this may allow for the use of other adhesive proteins 
besides HFN. Other cell types may require different proteins for proper attachment and 
guidance, so this platform will be versatile for a number of systems. Additionally, AAV2 
vectors are easily modifiable to include overexpression cassettes and shRNA cassettes, 
leading to the efficient upregulation and downregulation of many combinations of genes 
that may be of interest for tissue engineering applications. Moreover, AAV is an 
attractive viral platform because there are currently 12 identified serotypes, each 
serotype having the ability to deliver genetic cargo to different cell types within the body. 
The virus can also be modified through the introduction of a targeting ligand into the 
virus capsid.26· 56 Finally, there are a number of directed evolution procedures that can 
be implemented to increase tropism to a desired cell type. 27· 29· 32.34· 57 Overall, our 
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versatile platform allows for the facile creation of different patterns, as well as the 
attachment and potential targeting of many cell types. 
Interestingly, when AAV is adsorbed to an HFN layer, there are a variety of surface 
chemistries that are capable of supporting the surface immobilization needed for 
successful reverse transduction. Previous studies on retrovirus or adenovirus have 
suggested that virus adsorbed directly on -CH3 terminated alkanethiol surfaces may 
denature or fail to release these viruses. 19· 37 Similar to these results, we do not see 
acceptable transduction levels using AAV incubated directly onto SAMs. When analyzed 
on a -CH3 SAM, we find that without the use of a mediating HFN layer, gene expression 
is only 13% of that seen with the HFN layer (Figure 2.6A). Our immunostaining with an 
antibody that detects intact capsids only indicates the presence of undenatured AAV 
capsids on the -CH3 surface (Figure 2.3A). Therefore, inefficient release of AAV from the 
-CH3 surface may be the more likely explanation for the poor reverse transduction. Most 
surfaces show an increase in virus attachment when HFN is present (Figure 2.68). HFN 
pre-adsorption on -CH3 and -COOH SAMs yields an 80% increase in AAV2 attachment 
while pre-adsorption on -NH2 surfaces yields an almost 300% increase. As seen with a 
previous retrovirus study, successful transduction is observed from -CH3, -COOH, and -
NH2 surface chemistries when HFN is used as a protein mediating layer.37 This was a 
surprising result given that retroviruses and AAV have substantial structural and 
functional differences between the two virus particle surfaces. Retroviruses are -100 nm 
enveloped viruses, where the embedded envelope proteins mediate interactions of the 
virus with extracellular factors.58 AAV, in contrast, are 25 nm non-enveloped viruses, 
where patches of amino acid residues displayed on capsid surfaces allow the virus to 
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interact with extracellular factors. 49 These structural differences in conjunction with the 
knowledge that retroviruses and AAV infect different target cell types in vivo7 · 59, in part 
due to differences in virus particle surface-target cell surface interactions, we did not 
predict similar behavior of AAV and retroviruses on HFN. Further studies are necessary 
to determine more precisely how AAV is binding HFN. 
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Figure 2.6. AAV2 and HFN have a synergistic relationship. GFP expression was 
analyzed with or without the use of an HFN mediating layer on -CH3 SAMs (A). When 
compared to autofluorescence of Hela cells alone, fluorescence intensity measurements 
(as determined using lmageJ) are significantly higher (p<0.05). However, AAV2 alone 
yields only 13°/o of the fluorescence measured in the HFN pre-incubated sample. To 
help explain this result, we compared the integrated density values from immunostaining 
AAV2 on SAMs alone versus AAV2 on HFN pre-incubated SAMs (B). When compared, 
HFN preincubation yields an 80°/o increase on -CH3 and -COOH surfaces. For the -NH2 
surface, HFN pre-incubation yields an almost 300°/o increase in attachment. Pre-
incubation leads to no improvement on the -OH SAM, instead causing a 20°/o decrease 
in attachment. Error bars represent standard error of the mean (A) and propagation of 
error (B). 
An interesting outcome from this study was the discovery of a synergistic relationship 
between AAV2 and pre-adsorbed HFN. Specifically, presence of HFN significantly 
improves the ability of AAV to reverse transduce cells. The quantity of virus that 
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attaches to the substrate surface is higher when HFN is used to mediate adsorption. 
More interestingly, gene expression is nearly 8 times higher on surfaces pre-adsorbed 
with HFN. A possible explanation for this result is that AAV2 is able to bind HFN through 
electrostatic interactions. Previous reports have taken advantage of the negative charge 
of HFN in forming assembled layers.60· 61 AAV2 binds its natural receptor heparan 
sulfate, a negatively charged extracellular biomolecule, via patches of positively charged 
amino acids on the virus capsid.49 It is possible that AAV2 is able to bind negatively 
charged HFN using a similar electrostatic mechanism. Different conformations of HFN 
exist when adsorbed on different surfaces, potentially exposing variable binding regions 
of the protein.62· 63 This variation in exposed HFN domains could yield changes in 
attachment and detachment of the virus to and from HFN that is adsorbed onto different 
chemistries. Previous reports have identified interactions between fibronectin and 
retrovirus45, suggesting binding to fibronectin may be a common feature between these 
two viruses. To our knowledge, no reports exist of AAV2 binding HFN, therefore, more 
in-depth quantitative investigations are necessary to support this potential explanation. 
Microcontact printing is a versatile technique that has previously been applied to cellular 
localization studies. 12"14 Pattern formation for this method is simply controlled by the 
features on the elastomeric stamp and can easily be tailored to a desired size and 
pattern for a particular application. Additionally, various chemical surfaces can be 
created using different terminated alkanethiols. For this work we chose to test the 
efficacy of four different potentially protein adhesive groups: -CH3, -COOH, -NH2, and 
-OH. These various surfaces allowed us to test a spectrum of conditions, including 
hydrophobic/hydrophilic and negatively/positively charged surfaces, to determine the 
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optimal conditions for HFN and virus attachment. It is imperative to create an efficient, 
reversible immobilization. To prevent protein from attaching to the non-patterned 
regions of the substrate, we utilized an oligo(ethylene glycol) terminated alkanethiol 
solution to create a protein resistant layer. This layer successfully provided a crucial 
barrier to background protein attachment. 
As tissue engineering strategies continue to develop, incorporation of gene delivery 
vectors presented in spatially meaningful ways may become increasingly important. 
Here, we have demonstrated the ability to spatially localize both cells and gene delivery 
vectors. Importantly, we overcame the concern of virus localization - viral vectors must 
be tightly localized, but also be able to release efficiently to transduce cells. By being 
able to control the deposition of extracellular matrix proteins and gene delivery vectors, 
we are able to control both cell localization and spatial gene delivery. In the future 
extension of this work, we will endeavor to create complex virus patterns underneath the 
cell patterns. This will lead to a clear advantage over creating cell patterns and adding 
gene vectors suspended in the bulk media. In this latter approach, all of the cells will be 
transduced by the viral vectors, yielding no formation of a gene expression pattern. In 
our approach, we should be able to pattern multiple different gene vectors, each 
encoding different transgenes, underneath a cell pattern. By combining variable virus 
patterns with cell patterns, complex blueprints for tissue genesis can be designed. 
Studies are underway to separate virus patterning from cell patterning so that these 
features can be controlled independently. 
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2.6 Conclusions 
We have demonstrated the ability to precisely localize the immobilization of both 
extracellular matrix proteins and viral gene delivery vectors. Patterns were isolated to 
the desired area without background attachment. Through the use of microcontact 
printing, we have shown there are a variety of surface chemistries capable of 
immobilizing both HFN and AAV, and allowing for efficient viral transduction and gene 
expression. This effective approach has been shown for Hela cells and a model 
reporter gene but can be translated to other cell types and multiple AAV vectors 
delivering either overexpression or shRNA cassettes. In the future, more complicated 
structures can be created by patterning different combinations of adhesive proteins and 
viral vectors. Approaches such as this should support the future generation of 
structurally and functionally complex tissues. 
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CHAPTER THREE 
Investigating the effect of adhesive proteins on substrate-mediated virus 
gene delivery 
3.1 Acknowledgments 
I would like to thank Dr. Lisa Biswal, Jinghui Wang, and Dr. Joff Silberg for helpful 
discussions regarding protein binding studies. 
3.2 Introduction 
The creation of realistic in vitro tissue engineered constructs has yet to become a reality. 
A crucial hurdle in this development is the ability to efficiently localize and deliver genes 
in necessary spatial orientations. In Chapter 2 we have shown that microcontact printing 
and adena-associated virus could be used synergistically with human fibronectin to 
localize high efficiency gene delivery. In this chapter we have investigated the ability of 
other adhesive proteins to be used in this platform technique. 
We have previously demonstrated in Chapter 2 that microcontact printing is an effective 
method for spatially localizing gene delivery using AAV. Using PDMS stamps and 
protein adhesive alkanethiol solutions, we are able to create patterns of both human 
fibronectin (HFN) and AAV2-GFP (recombinant virus encoding the gene for GFP) to 
modulate both cellular adhesion and gene delivery. Interestingly, we discovered there 
was a synergistic relationship between the pre-adsorption of HFN and both virus 
attachment and efficient gene delivery. The use of an HFN mediating layer not only 
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allows for cellular adhesion, but also increases the amount of virus adsorbed as well as 
the efficacy of delivery. 
In this chapter, we have explored additional adhesive proteins (collagen I, laminin, 
elastin, and poly-1-lysine) to determine if they are 1) capable of working within our 
platform technology and 2) display any synergistic relationship with AAV2. PDMS 
stamps were prepared by inking in 2 mM of various protein adhesive alkanethiol 
solutions and were then placed on a gold-coated substrate. Samples were backfilled 
with an -OEG terminated alkanethiol to passivate the coverslip background. Coverslips 
were then incubated with adhesive protein, followed by AAV2-GFP. Finally, samples 
were either immunostained to observe virus deposition or seeded with Hela cells for 
analysis of cell adhesion and gene expression. By examining a variety of adhesive 
proteins, we have determined that pre-adsorption of laminin leads to significantly 
increased AAV2 transduction efficiency. This effect cannot be explained by changes in 
transcription rate due to ceii-ECM interactions. 
3.3 Materials and Methods 
Virus preparation. AAV2-GFP was prepared as described previously in Chapter 2. 
Viral titers were determined using quantitative polymerase chain reaction (QPCR) with 
primers for the CMV promoter of the cassette. Virus used in this study was determined 
to have a concentration of 1 e12 vector genomes/ml in 40% iodixanol. 
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PDMS stamp preparation and surface functionalization. PDMS stamps were 
prepared as described in Chapter 2. PDMS stamps displaying 500 pm diameter circles 
with a 1.2 mm pitch were cleaned by sonication in 100% ethanol. Gold-coated glass 
coverslips (35 mm diameter, 1 00 A gold over 20 A titanium, Platypus, Madison WI) were 
cleaned in dilute TL 1 solution (6:1 :1 H20:NH40H:H20 2) for 1 min at 80°C, rinsed twice in 
Millipore purified water (MPH20), and dried with ultrapure nitrogen (N2). Alkanethiols 
were diluted to 2 mM in 100% ethanol. Stamps were inked with either a -CH3 
(1-hexadecanethiol), -COOH (16-mercaptohexadecanoic acid), or -NH2 (11-amino-1-
undecanethiol hydrochloride) terminated alkanethiol, all from Sigma Aldrich (St. Louis, 
MO). Patterns were created by inking PDMS stamps, placing them gently on the 
substrate for 20 sec, and then carefully removing. Coverslips were then incubated with 
2 mM oligo(ethylene glycol) (-OEG) terminated alkanethiol (HSCwEG6, Prochimia, 
Poland) for 1 h to passivate the background. Samples were rinsed with 100% ethanol 
and dried with N2. 
Protein attachment. Functionalized coverslips were incubated with 1 ml protein 
warmed to 37°C diluted in phosphate buffered saline (PBS, pH 7.0) for 30 minutes. 
Human fibronectin (HFN, Sigma Aldrich, Franklin Lakes, NJ) was used at a 
concentration of 25 11g/ml. Bovine collagen I was used at a concentration of 50 11g/ml 
(Becton Dickinson). Human laminin was used at a concentration of 25 11g/ml (Sigma 
Aldrich). Soluble elastin was obtained from Spectrum Chemical (Gardena, CA) and was 
used at a concentration of 100 11g/ml. Poly-1-lysine (PLL) from Sigma Aldrich was used 
at a concentration of 50 11g/ml. Coverslips were rinsed twice with 5 ml of PBS using a 
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platform rocker. Virus was incubated with protein pre-adsorbed coverslips for 30 min at 
room temperature. Samples were again rinsed twice with PBS. 
/mmunostaining. Samples were blocked with 1% BSA in PBS for 1 h and rinsed twice 
with PBS. Patterns were incubated with A20 antibody (mouse anti-AAV2 capsid, 
American Research Products, Belmont MA) diluted 1:200 in PBS overnight at 4°C. 
Samples were rinsed with PBS and incubated with goat-anti-mouse AlexaFiuor 532 
conjugated antibody (Invitrogen) diluted 1 :100 in PBS for 1 h at room temperature. 
Coverslips were rinsed with PBS and mounted using Fluromount (SouthernBiotech, 
Birmingham, AL). 
Cell studies. Coverslips were placed in 60 mm tissue culture dishes and HeLa cells 
were seeded at a density of 100 cells/mm2. Cells were seeded in Dulbecco's Modified 
Eagle Medium (Invitrogen) supplemented with 1% penicillin/streptomycin (Invitrogen). 
After 8 h, media was exchanged to Dulbecco's Modified Eagle Medium supplemented 
with 1% penicillin/streptomycin and 10% fetal bovine serum (Invitrogen). Cells were 
maintained at 37 oc with 5% C02. At 72 h post-seeding, cells were fixed in 4% PFA-
PBS and stained with 2 11g/ml Hoechst 33342 stain (Invitrogen). Coverslips were 
mounted using Fluoromount. For BrU studies, cells were incubated with 2 mM BrU 
(Sigma Aldrich) for 1 h and permeabilized with 0.25% Triton X in PBS. Cells were 
blocked with BSA and rinsed with PBS. Primary anti-BrdU antibody (Sigma Aldrich) and 
secondary antibody (goat-anti-mouse AF532 conjugated, Invitrogen) were incubated for 
1 h each at a 1 :200 dilution in PBS. Samples were mounted using Fluoromount. 
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Imaging and image analysis. Images were acquired using a Zeiss 5 LIVE confocal 
microscope (Carl Zeiss, Munich, Germany). Images within a given sample set 
(immunostaining, GFP expression, Hoechst staining, BrU analysis) were acquired under 
identical conditions. Virus immunostaining images were collected using a 532 nm 
excitation at 50% power and data was collected for 2 ms pixel dwell time using a 
bandpass filter between 550-600 nm. GFP images were obtained using a 489 nm 
excitation at 1.8% power and data was collected for 2 ms pixel dwell time with a 
bandpass filter between 500-525 nm. BrU immunostaining images were collected using 
a 532 nm excitation at 3% power and data was collected for 2 ms pixel dwell time using 
a bandpass filter between 550-600 nm. To quantify virus attachment, 10 images were 
taken and integrated densities were measured with lmageJ (NIH, Bethesda MD). For 
cellular studies, ten fluorescence and DIG images were taken of each sample (five 
images from two independent replicates). For BrU analysis, the integrated density of 20 
cell nuclei per sample were determined. Data is given as mean and standard error of 
the mean. Statistical testing was performed using JMP 9. Significance was determined 
using ANOVA and post-hoc testing using Tukey's HSD with a p < 0.05. 
3.4 Results 
Localization of AA V2 onto protein surfaces. We have previously shown in Chapter 2 
that HFN is capable of increasing the efficiency of AAV2 adsorption to an alkanethiol 
surface. Here, we have examined the effect of using bovine collagen I, poly-1-lysine 
(PLL), laminin, and elastin as both cellular adhesion molecules and as aids for AAV 
deposition. We also included analysis of HFN at a higher concentration of AAV2-GFP. 
First, alkanethiol surface patterns were created by using PDMS stamps with 500 11m 
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circular patterns using chains with -CH3, -COOH, or -NH2 terminal groups. Samples 
were backfilled with an -OEG terminated alkanethiol. Adhesive protein was first 
adsorbed to the patterns in order to form a protein monolayer, followed by incubation 
with AAV2-GFP. Samples were rinsed, blocked, and incubated with an anti-AAV2 
primary antibody (A20) and a fluorescently tagged secondary antibody (AF532). 
Integrated density measurements of individual spots were determined for each protein 
and surface chemistry (Figure 3.1 ). A20 antibody only recognizes intact AAV2 particles, 
indicating that the signal we observe is from undenatured virus particles. When each 
protein is compared, we observe that HFN is capable of localizing significantly more 
AAV2, when -CH3 surfaces are compared. Elastin is capable of adsorbing the next 
highest amount of virus, and laminin immobilizes the least. It is also important to note 
that for each case, significantly more protein is immobilized onto the -CH3 SAM surface. 
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Figure 3.1. AAV deposition varies on adhesive protein surfaces. AAV deposition 
was determined through immunostaining and quantified using lmageJ. Ten images of 
each condition (alkanethiol surface and adhesive protein combination) were taken for 
quantification. For each adhesive protein, the -CH3 surface yields the highest levels of 
AAV2 attachment. When comparing individual proteins, HFN yields the highest levels of 
attachment over other proteins. Within each protein , significance over -COOH surfaces 
is indicated by * and over -NH2 is indicated by+ (p<O.OS). 
Gene delivery from protein surfaces. Ultimately, we are interested in the effect of 
different proteins on the gene delivery efficiency of AAV. To test this, we again created 
patterns with both adhesive protein and virus adsorbed in circular patterns. Hela cells 
were seeded on these patterns and samples were incubated for 72 h. Coverslips were 
then fixed and stained with Hoechst. Figure 3.2 displays DIC and fluorescence images 
of cells on different adhesive proteins, each adsorbed to -CH3 SAMs. For all protein 
surfaces, the greatest levels of cellular coverage are seen on -CH3 surfaces. All three 
surface chemistries yield high transduction levels. 
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Figure 3.2. Cell adhesion and gene expression on various protein surfaces. Hela 
cells were seeded at a density of 100 cells/mm2 and fixed 72 hours post seeding. 
Proteins are adsorbed to -CH3 SAMs. Successful gene expression is observed on all 
protein surfaces. Scale bar is 100 microns. 
For each sample, the integrated density of both the GFP signal and Hoechst signal were 
determined using lmageJ. The GFP signal was normalized to the nuclear signal in order 
to normalize expression to the number of cells on the pattern (Figure 3.3). When 
individual proteins are compared, laminin and HFN led to significantly higher GFP 
expression (p<0.05). When SAM surfaces for each protein are compared, HFN, elastin, 
and laminin surfaces all show significantly higher GFP expression on the -CH3 surfaces. 
For HFN and laminin surfaces, the -COOH surfaces have higher gene expression than 
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the -NH2 surfaces. Gene expression levels on collagen and PLL surfaces are 
statistically similar. From this analysis, we observe the highest level of gene expression 
when AAV2 is adsorbed onto laminin pre-coated patterns. As seen previously, Hela 
cells seeded onto HFN and AAV2 surfaces also yields high levels of gene expression. 
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Figure 3.3. Quantification of GFP expression. Hela cells were seeded onto adhesive 
protein and AAV2-GFP co-patterned samples. Cells were fixed and Hoechst stained 
72 h post cell seeding. HFN and laminin pre-adsorption leads to significantly higher 
levels of GFP expression. Five images each from two experiments were quantified for 
gene expression and nuclear staining using lmageJ. GFP expression was normalized to 
nuclear staining. Within each protein, significance over -COOH surfaces is indicated by 
* and over -NH2 is indicated by+ (p<0.05). 
Ultimately, we would like to know the relationship between immobilized virus and gene 
delivery efficiency. To relate these values, we normalized the gene expression levels to 
the relative amount of virus adsorbed, as measured by immunostaining (Figure 3.4) . 
Again, laminin pre-adsorption yields dramatic results with a much higher ratio of gene 
expression: virus adsorption. The ratio of gene expression to virus adsorption for laminin 
is approximately twice as high as HFN. When we compare the GFP/A20 ratio for each 
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protein -COOH surface, laminin surfaces show significantly higher gene expression over 
all four other proteins. HFN and collagen I gene expression is higher than both elastin 
and PLL gene expression. 
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Figure 3.4. GFP expression normalized to virus deposition. Gene expression from 
laminin surfaces is more than twice that from HFN, and significantly higher than all four 
other protein surfaces. -COOH surfaces for each protein were compared. Significance 
over HFN surfaces is indicated by *, over collagen I is indicated by +, over elastin is 
indicated by " , over PLL is indicated by# (p<O.OS). 
To determine the reason for the dramatic gene expression increase on laminin surfaces, 
we hypothesized that the gain in expression could be due to two possible reasons. First, 
Hela cells could be inherently more transcriptionally active on laminin surfaces, making 
the expression of all gene products (including GFP) higher than on other surfaces. 
Second , there could be differences in the disassociation properties between the viral 
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particles and various protein surfaces that make laminin a more optimal substrate for 
gene delivery. 
Transcriptional analysis. We sought to first test the transcriptional activity of Hela 
cells on each of our surfaces using bromouridine (BrU) incorporation to compare the 
relative transcriptional activities on the surfaces (Figure 3.5). BrU incorporation levels 
were compared using ANOVA, and it was determined that p<0.05. We observe 
differences in cellular activity on different surfaces, as Hela cells are nearly twice as 
active on PLL-COOH surfaces as compared to HFN-CH3 surfaces. It is most interesting 
to note that transcriptional activity on laminin-CH3 surfaces is not significantly higher than 
cellular activity on any of the other protein-CH3 surfaces. This lack of increased activity 
on laminin surfaces suggests that the increase in transduction levels seen on these 
surfaces is due to a laminin-AAV specific interaction. 
c 
0 
+=i 
~ 
0 
a. 
L.. 
0 
0 
c 
Q) 
> 
2.5 
2 
1.5 
1 
~ 0.5 
Q) 
0::: 
0 
48 
p<0.05 
I I 
-COOH 
HFN Collagen I Elastin Laminin PLL 
Figure 3.5. Relative transcriptional activity for Hela cells seeded on various 
adsorbed proteins. Hela cells were seeded onto adhesive protein adsorbed onto 
SAMs. Cells were treated with BrU 24 h later and immunostained to observe BrU 
incorporation. The integrated densities of 20 cell nuclei per condition were quantified. 
Values were normalized to the HFN-CH3 surface. It was determined by ANOVA that the 
cases were significantly different (p<0.05). 
3.5 Discussion 
We have previously shown that HFN is capable of supporting AAV2 patterning by 
localizing both cells and gene expression. Our reverse transduction format allows us to 
modulate the spatial organization of gene delivery. Viral vectors are immobilized onto a 
substrate and cells are seeded on top, wh ich allows us to control gene expression by 
controlling the underlying pattern. This is in contrast to a bulk delivery system, which 
would lead to a uniform transduction of cells. Surprisingly, we have found that AAV2 is 
capable of interacting with a variety of adhesive proteins. This is a very important idea to 
note as we work to expand this technology. As we create more complicated structures, 
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we will integrate additional cell types into our constructs. Each cell type used may need 
to be supported by particular adhesive proteins, thus more flexibility in our system will be 
important. 
Interestingly, we have identified that laminin surfaces are most effective for AAV2 gene 
delivery. Laminin pre-adsorption yielded nearly twice as high transduction efficiency per 
immobilized virus capsid. We rationalized that this dramatic increase in transduction 
efficiency could be due to increased transcriptional activity of Hela cells on laminin 
surfaces. However, since BrU studies indicated that these cells are no more 
transcriptionally active on laminin surfaces as compared to other proteins, we believe 
that the interaction, particularly the release of virus from laminin, must be more efficient 
on laminin surfaces compared to other ECM proteins. This hypothesis is currently being 
explored using quartz crystal microbalance (QCM) and surface plasmon resonance 
(SPR) to more quantitatively study the deposition of virus on these proteins and the 
binding and release kinetics on these surfaces. 
The interaction of AAV with extracellular matrix proteins has not been studied 
extensively. While we know the primary cell receptors for several serotypes (e.g. AAV2 
binds heparin sulfate proteoglycans, AAV1 and AAV6 bind sialic acid64), very little is 
known about the interaction of AAV with ECM proteins. As various serotypes are known 
to transduce selected tissues within the body, the specific interactions that lead to these 
transduction events has not been identified. While it is presumed that these transduction 
effects are based on cell-binding interactions, the information we are learning about 
AAV-protein interactions creates additional questions about the interaction of these 
vectors with the surrounding supporting structures. 
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In addition to in vitro gene delivery studies, this work has implications for in vivo gene 
delivery. As targeting strategies for in vivo gene delivery continue to advance, it will 
likely be important that vectors are capable of transversing extracellular boundaries. 
Currently, little is known about the interaction between AAV serotypes and ECM proteins 
within the body. These interactions could be crucial for efficient gene delivery, as it has 
previously been shown that co-injection of heparin with AAV2 vectors in the brain 
allowed vectors to travel farther into the brain.65 It has also been shown that retinal 
transduction is increased with the digestion of the inner limiting membrane by protease.66 
AAV5, for example, is unable to delivery genes efficiently to the inner retinal cells unless 
this membrane is digested.66 The authors suggested that this was due to a lack of 
appropriate receptors for this membrane. 
Other viral vectors have been shown to interact with protein. Fibronectin has been 
shown to localize retroviral vectors to target cells as retrovirus is capable of associating 
with a heparin binding domain on fibronectin. This interaction can be blocked by addition 
of heparin.67 Cell binding domains on fibronectin allow the protein to interaction with 
cells, while retrovirus is brought in contact to cells through interaction with the heparin 
binding domain. RetroNectin (Takara Bio Inc, Madison, WI) is a fibronectin-based 
technology developed based on these interactions. Plates coated with RetroNectin can 
be incubated with retrovirus or lentivirus, and then seeded with cells to increase virus-
cell interactions and increase gene delivery within cells.68• 69 
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3.6 Conclusions 
In this chapter we have explored the efficacy of adsorbing AAV2 to a number of 
adhesive proteins. We have used PDMS stamps and protein adhesive alkanethiols to 
localize HFN, laminin, collagen, elastin, and PLL. AAV2 particles were immobilized to 
the pre-adsorbed protein. While all proteins facilitate cell adhesion and successful gene 
delivery, we observe that laminin pre-adsorption leads to the most successful gene 
delivery. We hypothesize that this could be due to 1) increased AAV2 transcriptional 
activity on laminin surfaces or 2} advantageous interactions between AAV2 and laminin 
that allow for more efficient virus release. BrU incorporation suggests that HeLa cells 
are no more transcriptionally active on laminin surfaces, suggesting that AAV2 release 
from laminin surfaces could be the reason for increased transduction efficiency. 
Currently, quartz crystal microbalance with dissipation (QCM-D) and surface plasmon 
resonance (SPR) studies are being developed to further explore this possibility. 
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CHAPTER FOUR 
Live-cell microarray surface coatings supporting reverse transduction by 
adena-associated viruses 
4.1 Acknowledgements 
I would like to thank Ryan Schwaller and Dr. Michael Diehl for assistance with robotic 
spotting and Jerry Leu for schematic creation assistance. 
4.2 Introduction 
Live cell genetic microarray technology is a potentially powerful approach to investigating 
the cell behavioral effects of expressing or knocking down various combinations of 
genes?0 Each spot of the microarray can contain a different combination of genes or 
RNAi cassettes, and live target cells are seeded on top of the spots. Through the 
process of reverse transduction (when viral vectors are used) or reverse transfection 
(when nonviral vectors are used), the cells will internalize the genes/RNAi cassettes 
resulting in the overexpression or knockdown of specific genes. Different gene 
expression profiles in each of the microarray spots may lead to phenotypic changes in 
the cells. Detecting these changes via automated imaging and image processing will 
provide a high-throughput combinatorial screening method that can help identify key 
gene expression profiles that yield a desired cellular outcome. 
Live cell genetic microarrays have previously been generated using both viral and 
nonviral gene delivery methods. 18· 20· 43• 71 Non-viral gene delivery methods have been 
used to generate single cell microarrays to study up to 600 cell spots on a single chip. 72 
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siRNA lipoplexes mixed with matrigel have been successfully arrayed onto poly-1-lysine 
coated slides for high-throughput siRNA silencing.73 The success of any live cell genetic 
microarray approach hinges upon the ability of vectors to deliver nucleic acids with high 
efficiency to cells of interest. Although nonviral delivery systems are promising, viral 
vectors in general still have significantly higher gene delivery efficiencies, supporting 
their continued development for genetic microarray technology. In terms of viral vectors, 
both adenovirus and lentivirus have been spotted under various conditions to create 
genetic microarrays. For example, lentivirus was spotted with a robotic spotter to create 
alternating patterns of overexpression and shRNA cassettes, and phenotypic changes in 
target cells were analyzed. 18 Fibrin hydrogels have been used to help immobilize 
lentiviruses in spot patterns, suggesting a difficulty in maintaining lentivirus spots without 
such an approach?4 Adenovirus microarrays have been created using a manual spotting 
device and 25 mg/ml nitrocellulose coated slides.43 Notably, a synthetic blocking agent 
was used to localize cell adhesion to areas of virus deposition, creating distinct cell 
islands. These previous studies have made great strides towards the creation of 
versatile, high-throughput genetic microarray technology, and we sought to improve 
upon the successes through the use of an alternate, potentially more advantageous 
gene delivery vector. 
Specifically, additional improvements in delivery efficiency and safety would enhance the 
potential for virus-based live cell genetic microarrays. A virus vector capable of being 
modified relatively easily to increase transduction specificity and efficiency would 
increase the power of this technology. Thus, we chose to investigate the potential of 
AAV for the creation of genetic microarrays. 
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AAV is an appealing alternative to the other viruses due to its increased safety profile 
and the relative ease with which its delivery efficiency can be improved. AAV is able to 
deliver genes into both dividing and nondividing cells. A number of naturally occurring 
serotypes of AAV have been identified, with each serotype displaying variable tropism. 7 
Numerous rational26· 56 and combinatorial27· 29· 75 methods have been developed to 
enhance gene delivery efficiencies into target cells. Furthermore, AAV is non-
pathogenic, meaning it is not known to cause any human disease. Recombinant AAV 
does not integrate effectively into the human chromosome, alleviating concerns over 
insertional oncogenesis. Due to the numerous positive features of AAV, we have initiated 
the development of AAV-based live cell genetic microarrays. 
To create AAV-based microarrays, a custom-built robotic spotter was used to deposit 
AAV serotype 2 (AAV2) encoding GFP (AAV2-GFP) onto glass slides (Figure 4.1 ). For 
the microarray to be successful, AAV must be localized into spots but retain the ability to 
release from the surface and transduce target cells. If virus affinity to the surface is too 
low, the virus patterns may dissipate quickly upon addition of cell seeding media, 
resulting in a lack of localized gene expression profiles. Conversely, if affinity to the 
surface is too high, vectors may adsorb irreversibly or possibly even denature, resulting 
in suboptimal gene delivery efficiencies. No previous reports exist testing AAV for 
microarray development; therefore, we screened several commonly used surface 
coatings for their ability to adsorb AAV. Specifically, three different glass slide coatings 
(gamma amino propyl silane [GAPS], amine silane, and nitrocellulose) were investigated 
to determine an optimal substrate for AAV immobilization and reverse transduction. 
Spot AAV2-GFP 
Dry samples 1 hour 
Incubate 72 hours 
Image for gene expression 
Block with filtered StabiiGuard 
Incubate 30 minutes 
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Figure 4.1. Schematic of patterning process. Recombinant AAV is spotted onto 
coated glass slides. Slides are backfilled with microarray stabilizer and then seeded with 
cells. Arrays are imaged three days later for gene expression. 
4.3 Materials and Methods 
Virus production. HEK 293T cells and a triple transfection method were used to create 
AAV2-GFP as described previously. 54 Virus was purified using ultracentrifugation and a 
step iodixanol gradient. Virus used in these experiments was purified using a heparin 
affinity column and dialysis against DPBS, as virus in iodixanol inhibited deposition from 
the array pin. Virus solution (1 ml) was added to a heparin column (GE Healthcare, 
Piscataway, NJ), rinsed with column buffer (150 mM NaCI, 1 0 mM Tris, 10 mM MgCI2) 
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and eluted with elution buffer (1 M NaCI, 10 mM Tris, 10 mM MgCI2). Eluted virus was 
added to a 10,000 molecular weight cut off dialysis cassette (Pierce, Rockford, IL) and 
dialyzed against three changes of DPBS over nine hours. Virus was titered using real 
time quantitative polymerase chain reaction (RT-QPCR) with primers against the CMV 
promoter in the recombinant virus cassette. 
Virus spotting. GAPS coated slides (Corning, Corning NY) and amine silane 
functionalized slides (CEL Associates, Pearland TX) were used as is. These slides 
should yield similar surfaces. Nitrocellulose (Sigma Aldrich, St. Louis MO) was dissolved 
in methanol at concentrations of 2-4 mg/mL. Glass slides were rocked for 1 h with 
nitrocellulose solutions at room temperature and then allowed to dry at room temperature 
for 1 h. Spotting was conducted using an in-house fabricated microarray robot and an 
SMP15 pin (7 nl delivery volume) from Arrayit (Sunnyvale CA). Slides were allowed to 
dry for 1 h and then backfilled with StabiiGuard (Surmodics, Eden Prairie MN) for 30 min. 
Slides were then rinsed with PBS. 
lmmunostaining. Slides were blocked with 1% BSA-PBS for 1 h, rinsed with PBS and 
then incubated with a 1 :200 dilution of A20 antibody (American Research Products, 
Belmont MA) at 4°C overnight. Microarrays were then rinsed with PBS and incubated 
with a 1 :100 dilution of a goat-anti-mouse AlexaFiuor 532 (AF532) conjugated antibody 
(Invitrogen, Carlsbad CA) for 1 h. Samples were washed with PBS and mounted using 
Fluoromount. Intensity plots were created using lmageJ. Lines were drawn through an 
image of 4 spots and the fluorescence intensity profile was plotted as a function of 
distance in microns. 
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Cell culture. Slides were seeded with Hela cells in a 10 em tissue culture dish. GAPS 
and amine functionalized slides were seeded at a confluency of 95% and nitrocellulose 
slides were seeded at a confluency of 20%. Cells were cultured in DMEM supplemented 
with 10% FBS and 1% penicillin/streptomycin (Invitrogen). Slides were moved to a new 
dish the next day and supplemented with fresh media. Slides were fixed with 4% PFA in 
PBS 72 h post cell-seeding. 
Imaging and analysis. Microarrays were imaged using a Zeiss LSM 5 LIVE confocal 
microscope (Carl Zeiss, Munich, Germany). Integrated densities were determined using 
lmageJ (NIH, Bethesda MD). Data is reported as average with standard error of the 
mean. Statistical significance was determined using ANOVA and Tukey's HSD for post 
hoc pairwise testing (p<0.05, JMP 9 software). 
4.4 Results 
Virus immunostaining. Deposition of AAV on the three different surfaces was 
visualized via immunostaining with an antibody that detects nondenatured AAV2 capsids 
only (Figure 4.2A-C). Spot diameter for all three cases is approximately 400 microns with 
a pitch of 800 microns, as expected. Although GAPS and amine silane coatings allow for 
localized AAV deposition, the density of nondenatured virus deposition is low, 
highlighted by low fluorescence values on the intensity plots (Figure 4.2D-E). Low levels 
of AAV2 adsorption on amine surfaces is consistent with our previous studies.76 An 
edge effect can be observed, where more virus is deposited along the edges of the 
spots. In contrast, the nitrocellulose coating yields bright virus staining, indicating a 
greater amount of nondenatured AAV is immobilized in the spotted area (Figure 4.2F). 
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Our previous work indicates a hydrophobic methyl (-CH3) surface is able to mediate high 
levels of AAV2 adsorption,76 suggesting the hydrophobic character of nitrocellulose may 
be responsible for effective AAV immobilization in this study. Interestingly, a higher 
distribution of AAV is observed along the center axis of the spot, likely attributable to the 
geometry of the microarray pin. The pin used in this study has a linear slit opening 
positioned at the center of the tip. The sample presumably flows out of the slit opening 
and spreads along the shape of the tip. 
A. .. .. 
' • 1 i ~ . . 
' . . '. 
... , .. -
8 
.. 
... ~ . . .. 
D 2so 
~ 200 
·u; 150 
c 2 100 
c 50 
0 
E 2so 
>. 200 
F 
...... 
·u; 150 
c (]) 100 
...... 
c 50 
0 
0 1 000 2000 3000 
Distance (microns) 
0 1 000 2000 3000 
Distance (microns) 
250 - - -
~ 200 
·u; 
c 
(]) 
...... 
c 
150 
100 
50 
0 
0 1000 2000 3000 
Distance (microns) 
59 
Figure 4.2. lmmunostaining of AAV deposition on three different coated glass 
slides. Virus was spotted onto (A) GAPS slides, (B) amine silane slides, or (C) 3 
mg/ml nitrocellulose coated slides. Samples were immunostained with an anti-AAV 
antibody and an AF532 conjugated secondary antibody. Scale bar is 500 microns. 
Images D-F are intensity plots generated over 4 spots using lmageJ. Bars at top of 
graphs indicate locations of virus patterns. While patterned deposition is observed on all 
surfaces, the most intense staining is seen with the nitrocellulose coated slides. 
Cell adhesion and gene expression. We next seeded cells on top of the virus patterns 
to test for reverse transduction. The immobilized AAV must release from the surface and 
be internalized by the cells in order to mediate successful gene delivery. This release 
cannot happen too quickly, otherwise virus patterns will be dispersed as they come into 
contact with cell media. Although GAPS and amine silane coated slides result in 
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positively transduced cells, the GFP-expressing cells are scattered and do not yield 
distinct patterns (Figure 4.3). The nonspecific affinity of AAV to these surfaces may not 
be strong enough to resist disassociation in media prior to cell attachment. In other 
words, as soon as cells and media are added to the virus patterned slides, the viruses 
may lift off and drift away from the established patterns. The nitrocellulose coated slide, 
however, successfully yields a pattern of GFP-expressing cells (Figure 4.4A), indicating 
AAV is able to release effectively off the surface. Cells are attached only to these 
discrete spot regions, with no cells adhering to the background (Figure 4.5). 
Interestingly, we observe a series of linear cell islands reflective of the higher AAV 
deposition along the center axis of the microarray pins (Figure 4.2C). We hypothesize 
that cells may be able to utilize specific receptor-ligand interactions to adhere to this 
region displaying higher amounts of AAV. AAV2 is known to bind heparan sulfate 
proteoglycans on target cell membranes.49 At sufficient concentrations, immobilized 
AAV2 may be able to mediate cell binding to the surface, as previously demonstrated.77 
In future optimizations, adding cell adhesive proteins to the virus solution could help 
generate complete spot formation. Alternatively, we may use a different shaped pin to 
obtain a more uniform virus deposition. In future optimizations, adding cell adhesive 
proteins to the virus solution could help generate complete spot formation. Alternatively, 
we may use a different shaped pin to obtain a more uniform virus deposition. 
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Figure 4.3. Cell adhesion and gene expression on amine slides. As suggested in 
Figure 4.2, virus deposition onto GAPS II (top) and amine silane functional ized slides 
(bottom) leads to semi-local ized gene expression with an undesirable level of spreading. 
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Figure 4.4. Cell adhesion and gene expression on nitrocellulose coated slides. 
AAV was printed on nitrocellulose coated glass slides and Hela cells were seeded on 
top of the virus patterns. (A) Pattern of GFP-expressing cells can be observed on 3 
mg/ml nitrocellulose coated slides at 72 h post cell seeding. Cells are located only within 
the patterns. Scale bar is 500 microns. (B) 2-4 mg/ml nitrocellulose coatings yield similar 
levels of reverse transduction. The differences are not statistically significant. (C) 
Different concentrations (virus genomes/ml) of AAV were used in the spotting and 
efficiency of reverse transduction quantified. A dose-dependent response in gene 
expression is observed, with significantly less gene expression observed with virus at 
concentrations of 5x1 010 and 1 x1 011 vg/ml (p<0.05). 
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Figure 4.5. DiC image of localized spot. DIC image of Hela cell spot on 3 mg/ml 
nitrocellulose slide. 
We next sought to optimize the promising nitrocellulose coating by testing different 
nitrocellulose concentrations (Figure 4.48). Preliminary tests indicated coatings with 
higher than 4 mg/ml nitrocellulose are not efficient for gene delivery and less than 
1 mg/ml leads to undesirable virus spreading (Figure 4.6). In the concentration range of 
2-4 mg/ml nitrocellulose, we observe similar levels of GFP expression in the cells. We 
also investigated the minimum concentration of virus needed to obtain significant gene 
expression from the nitrocellulose surface (Figure 4.4C). Using a 3 mg/ml nitrocellulose 
coated substrate, we spotted 5x1 010 to 1 x1 012 viral genomes (vg)/ml AAV solutions. A 
sharp decrease in gene expression is observed when a virus solution under 5x1 011 vg/ml 
is used. Based on a spot size of 400 microns and a pin deposition volume of 7 nl, we 
estimate a virus concentration of 3x1 011 vg/ml is required to create a monolayer of virus. 
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Due to inefficiencies in the system, we likely do not have a monolayer and not all AAV 
that is bound is able to release effectively and deliver genes into target cells. 
Figure 4.6. GFP expression on additional nitrocellulose concentration surfaces. 1 
mg/ml nitrocellulose coating leads to spread cell adhesion (A) and non-localized gene 
expression (B). 5 mg/ml nitrocellulose coating leads to low levels of gene expression 
within a spot (C & D). 
4.5 Conclusions 
In summary, our AAV-based live cell genetic microarray platform is a promising 
alternative to platforms using other viruses. AAV has a demonstrated track record of 
being readily modified to improve gene delivery efficiencies and specificities. Moreover, 
AAV has a greater safety profile compared to other viruses, supporting its continued use 
and investigation in gene delivery applications. We have demonstrated that AAV can be 
patterned using a robotic spotter. The immobilized AAV is capable of releasing from the 
nitrocellulose surface and mediating effective reverse transduction. Further optimizations 
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of our method will take us closer to the development of a microarray technology for high-
throughput combinatorial genetic screening that may help identify unique gene 
expression profiles necessary for reprogramming iPS cells or differentiating stem cells. 
For example, combinatorial gene expression screening in induced pluripotent stem cells 
(iPS) may reveal improved gene combinations for more efficient stem cell 
reprogramming. Current iPS technology, relying on the delivery of genes encoding four 
transcription factors, has a success rate of less than 1%.78 Substantial enhancements to 
iPS reprogramming may be made by identifying improved combinations of genes to 
deliver. Investigations into stem cell differentiation can also benefit from a live cell 
genetic microarray technology. Stem cell differentiation is a complicated multi-step 
process involving an array of genetic changes, cell interactions, as well as additional 
factors. 11 To better understand the effects of genetic factors on differentiation, the 
effects of these genes must be tested in combination and analyzed for downstream 
implications. An improved high-throughput genetic microarray technology would allow 
researchers to conduct these experiments in an efficient manner to analyze the interplay 
of genes responsible for complex cell behaviors. 
CHAPTER FIVE 
Reprogramming virus nanoparticles to bind metal ions upon activation 
with heat 
5.1 Acknowledgements 
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5.2 Introduction 
In this chapter we will re-program the virus output in order to study AAV as a potential 
biosensor. Instead of using the virus to infect cells, we will take advantage of virus 
capsid conformational change dynamics in order to modify the output of our virus 
vectors. Modified vectors could then be patterned using a high-throughput approach to 
assay for biomolecules of interest. 
We are focused on investigating whether the dynamic functionalities of the AAV capsid 
can be reprogrammed in pursuit of our goal to develop novel, intelligent, genetically 
encoded nanoparticles. In particular, our proof-of-concept study endeavored to exploit 
the stimulus-responsive conformational change behavior of the virus capsid in order to 
externalize metal-binding motifs upon activation. Such virus nanoparticles (VNPs) can be 
interfacial building blocks, guiding the organization and creation of higher order 
structures using metals as assembly center.79 Ideally, we would like to employ the 
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conformational change dynamics exhibited by AAV to function as a biosensing device 
(Figure 5.1 ). Virus nanoparticles would be modified such that their input would be a 
desired stimulus (likely a protein or small molecule of interest) and their output would be 
a domain that we could efficiently detect (fluorescent particle, enzymatic domain, 
detectable tag) . 
Viral particle with 
internalized domain 
Small molecule/protein binding 
Heat activation 
Exposure to desired stimulus 
elicits conformational change 
Detect externalized 
domains 
Figure 5.1. Alteration of AAV VNPs for biosensing. To use AAV as a biosensor, we 
envision replacing the PLA2 domain on the VP1 N-terminus with a detectable domain 
(left) which would be internalized until activation. VNPs could be activated through the 
binding of a small molecule or protein (center, top) or through a current stimulus, heat 
activation (center, bottom). Treatment with stimuli would lead to externalization of these 
residues and detection of the inserted domains (right). 
The end goal of this work would be to create arsenals of different VNPs, each capable of 
activation under different stimuli. VNPs would then be patterned unto a suitable 
substrate using a high-throughput microarray spotter (Figure 5.2). Viral particles 
68 
recognizing biomolecules of interest would be arrayed, dried , and the patterned chip 
would be blocked with a microarray stabilizer. Sensor chips would then be exposed to a 
solution containing potential biomolecules of interest. After activation of virus particles 
and externalization of N-terminus residues the sensor chip would be imaged. Viral 
particles detecting molecules within the solution would be activated , while those not 
responding to any of the present molecules would remain in the native state. 
Pattern particles recognizing 
selected biomolecules 
Assay for activated viral 
particles 
Block microarray with 
StabiiGuard 
l 
Apply solution to be tested 
Figure 5.2. High-throughput patterning of AAV biosensors. We envision patterning 
modified VNPs using a microarray spotter. VNPs sensing selected biomolecules will be 
patterned into individual spots and blocked using StabiiGuard. Solution containing 
biomolecules to be tested will be applied to the array. VNPs responding to molecules in 
the solution will be activated. 
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Viruses have gained considerable interest as genetically encoded nanoscale structures 
that can be harnessed to create novel materials with unique properties and 
functionalities. For example, the rod-like M13 bacteriophage has been used to generate 
semiconductor nanowires80 and to create cell substrates for the guidance of neuronal 
progenitor cells, 81 while MS2 bacteriophage has been investigated as a taxol drug 
delivery scaffold. 82 Plant viruses, such as cowpea mosaic virus83 and cowpea chlorotic 
mottle virus84 have been used as protein scaffolds for biomineralization of heavy metals. 
Cowpea mosaic virus has also been investigated as a nanoparticle for the imaging of in 
vivo vasculature,85 as an MRI contrast agent,86 and for potential use as electroactive 
biomaterials or biosensors. 87 Brame mosaic virus, another plant virus, has been studied 
as an encapsulation agent for negatively charged gold or iron oxide nanoparticles to be 
potentially utilized as imaging and tracking agents.88• 89 Tobacco mosaic virus has been 
used to create thin film surfaces for the detection of methanol and ethanol vapors.90 
Each virus system has a unique set of characteristics, thus providing a diverse range of 
structures and functions that can be leveraged for the creation of new nanostructures for 
human application. 
Adena-associated virus (AAV) has so far mainly been used for gene therapy 
applications, with at least 75 human clinical trails underway. The biology pertaining to 
AAV structure and function is an area of intense investigation by numerous groups? We 
are focused on investigating whether the dynamic functionalities of the AAV capsid can 
be reprogrammed in pursuit of our goal to develop novel, intelligent, genetically encoded 
nanoparticles. In particular, our proof-of-concept study endeavored to exploit the 
stimulus-responsive conformational change behavior of the virus capsid in order to 
externalize metal-binding motifs upon activation. Such virus nanoparticles (VNPs) can be 
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interfacial building blocks, guiding the organization and creation of higher order 
structures using metals as assembly centers. 79 
The simple genome of AAV is composed of two genes: rep and cap. The rep gene 
encodes for four non-structural proteins that are integral in virus replication. The cap 
gene encodes for three structural proteins, VP1, VP2, and VP3 (Figure 5.3A). The VPs 
share a common C-terminus and self-assemble in a 1 :1 :10 ratio to form a 60 subunit 
icosahedral capsid. A fourth protein also encoded by cap, assembly activating protein 
(AAP), activates this self-assembly process.5 When assembled, the capsid contains 
twelve pore structures at the five fold axes of symmetry. 
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~P.His 
Figure 5.3. Overall design of metal-binding virus nanoparticles (VNPs). (A) The 
PLA2 region of VP1 in the wildtype (wt) virus was excised and replaced with a 
hexahistidine tag (His6) in order to create the AAV2-~PLA2-His (~P.His) construct. The 
first amino acid residue number corresponding to the antibody binding sites for A69 and 
81 are indicated. Plasmid constructs are used to generate VNPs by transfecting into 
293T cells along with pXX6. Wt virus contains an internalized PLA2 domain and ~P.His 
virus contains the His6 tag. (B) Viruses are exposed to heat to activate the capsid 
conformational change. Upon stimulation, ~P.His VNP surface exposes His6 tags. 
Notably, the AAV capsid is capable of undergoing a dynamic conformational change 
upon exposure to specific stimuli - low pH and additional unknown endosomal factors in 
cells and heat or urea shock in the laboratory. 23· 24 Exposure to low pH alone is not 
sufficient to induce this conformational change. 91 Upon stimulation, the N-termini of VP1 
and VP2, which have been identified as globules located inside capsid lumens prior to 
activation, 24 become externalized on the capsid surface. This externalization is 
hypothesized to occur through the pores at the five fold axes of symmetry. The 
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conformational change requires the presence of encapsidated viral genome24 and 
specific amino acid residues at certain locations.23 The externalized VP1 N-terminus 
contains a catalytic phospholipase A2 domain (PLA2), hypothesized to enable AAV to 
escape from endosomes and avoid lysosomal degradation. Externalization of these 
protein domains can be detected using antibodies, namely A69 (epitope located on both 
VP1 and VP2) (Figure 5.3a). 
While externalization of the PLA2 domain in vivo is crucial for virus infectivity, for our 
goal of developing novel nanoscale materials we sought to reprogram this functionality 
by replacing the domain with other functional motifs. As the first proof-of-concept 
demonstration that the AAV capsid is amenable to such alteration and retains its 
dynamic behavior, we have created VNPs that develop the ability to bind metal upon 
external activation. To achieve this function, we replaced the PLA2 domain with a 
hexahistidine (His5) tag (Figure 5.3). We show the VNPs maintain wild-type (wt) like 
dynamic behavior and, upon exposure to heat, develop the ability to bind nickel (Figure 
5.3b). 
5.3 Materials and Methods 
Mutant plasmid construction. Plasmid AAV2-D.PLA2-His was constructed using the 
AAV2 wild-type genome. Genes rep and cap were excised from plasmid pSub201 using 
an Xbal restriction digest and cloned into vector pBiuescript II SK (+) (Agilent, Santa 
Clara, CA). Using site-directed mutagenesis (Agilent), an Eagl site in the multiple 
cloning site of pBiuescript was silenced. An Eagl site was introduced directly upstream 
of the PLA2 domain and consecutive Eagl and Mlul sites were introduced directly 
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downstream. The vector was digested with Eagl and religated, removing the PLA2 
domain and allowing for the insertion of a hexahistidine tag through directional cloning. 
The cap fragment was then excised and cloned back into the AAV2 genome flanked by 
ITRs. 
Virus production. Virus was produced as described elsewhere.54 Briefly, plasmid 
AAV2-b.PLA2-His or pSub201 were co-transfected with pXX6 (to create mutant or wild-
type virus, respectively) into 293T cells using polyethylenimine. Virus was isolated using 
ultracentrifugation and an iodixanol step gradient. Virus titers were determined by 
quantitative real-time PCR (QPCR) using SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA) with primers directed against rep. 
Western and dot blots. For Western blot analysis of capsid proteins, wild-type AAV2 
and AAV2-b.PLA2-His were denatured in NuPAGE LOS buffer for 30 minutes at 75°C. 
Samples were electrophoresed in NuPAGE 7% Tris-acetate gels according to 
manufacturer protocol (Invitrogen, Carlsbad, CA). Protein was then wet transferred to 
Hybond ECL nitrocellulose membrane (GE Healthcare, Piscataway, NJ) and blocked in 
5% skim milk in PBS-T (137 mM NaCI, 2.7 mM KCI,10 mM Na2HP04, 2 mM KH2P04, 
0.1% Tween-20). Membranes were probed for VP capsid proteins and His6 tag using 
mouse monoclonal 81 and a-His antibodies, respectively (both 1:50 dilution; American 
Research Products), followed by incubation with HAP-conjugated goat anti-mouse lgG 
antibody (1 :2000 dilution; Jackson lmmunoresearch, West Grove, PA). Lumi-Light 
Western blotting substrate (Roche Diagnostics, Indianapolis, IN) was added to each 
membrane and the resulting stains digitally visualized. 
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For immuno-dot blot detection of externalized N-termini and His6 tags, virus was diluted 
in PBS (137 mM NaCI, 2. 7 mM KCI, 10 mM Na2HP04, 2 mM KH2P04) and transferred to 
nitrocellulose membrane using a Bio-Dot microfiltration apparatus according to 
manufacturer protocol (Bio-Rad, Hercules, CA). Membranes were incubated with 
monoclonal mouse A20, A69, B1, or a-His antibodies (American Research Products) 
and visualized as above. 
Heparin binding assay. Wild-type and AAV2-~PLA2-His VNP heparin binding profiles 
were determined by using HiTrap Heparin HP columns (GE Healthcare). The column 
was loaded with 500 Ill of 1-5e12 virus genomes/ml and eluted with increasing 
concentrations of NaCI solution. Fractions from each elution were collected and titers 
were determined by using QPCR with primers against rep. 
Nickel column purification. Binding of VNP to nickel affinity columns was quantified 
using QPCR. Wild-type and AAV2-~PLA2-His VNP (1-5e12 virus genomes/ml) was 
incubated at 37°(n=2), 60°(n=5), 63°(n=3), 65°(n=9), or 75°C (n=2) for 30 min and 
loaded onto His SpinTrap nickel affinity columns (GE Healthcare). Columns were 
washed with 20 mM imidazole and eluted with three applications of 500 mM imidazole 
solution. Fraction titers were determined using QPCR as above. 
Statistical analysis. Statistical analysis was performed using SPSS v11.5 (IBM). One-
way ANOVA calculations were performed to compare the various groups and Bonferroni 
post-hoc analysis was utilized to find differences. P values less than 0.05 were reported 
as statistically significant. 
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5.4 Results 
Successful replacement of PLA2 domain with His6 tag. We have created a virus 
variant, named AAV2-6PLA2-His, where the PLA2 domain has been replaced with a 
His6 tag. Utilizing site-directed mutagenesis, we replaced the native PLA2 domain 
located on the N-terminus of VP1 subunit with nucleotides encoding for a His6 tag. After 
verification of correct plasmid sequence (data not shown), we used the triple transfection 
method followed by ultracentrifugation on an iodixanol step gradient to obtain the VNPs. 
The titer of AAV2-6PLA2-His, as quantified with real-time quantitative PCR (QPCR), is 
equivalent to wild-type capsid AAV2 (wtAAV), ranging from 4.3 x 1012 to 2.9 x 1013 virus 
genomes/ml depending on the batch. To confirm proper expression of the His6 tag in the 
VP1 capsid subunit, Western blots were performed using 81 and anti-His6 (a-His) 
antibodies (Fig. 5.4). The 81 antibody binds to the C-terminus of all three capsid 
subunits. The 81 blot confirms a smaller VP1 subunit in AAV2-6PLA2-His due to 
replacement of the 60 amino acid (aa) PLA2 domain with the 6 aa His6 tag (Fig. 5.4, left). 
The VP2 and VP3 proteins are of equal size, as expected, in comparison between the 
AAV2-6PLA2-His and wt virus. In addition, AAV2-6PLA2-His qualitatively has the proper 
1:1 :10 stoichiometric ratio of the three capsid subunits. Utilizing the a-His antibody, we 
confirm that only VP1 in AAV2-6PLA2-His contains the desired His6 tag (Fig 5.4, right). 
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Figure 5.4. Successful generation of AAV2-.dPLA2-His VNP. (Left) Western blot of wt 
and AAV2-~PLA2-His (~P.His) VNPs using 81 antibody that binds to the C-terminus of 
all three capsid proteins. Blot demonstrates smaller VP1 of AAV2-~PLA2-His VNP due 
to replacement of PLA2 domain with a substantially shorter His6 tag. Sizes of VP2 and 
VP3 are unchanged. (Right) Western blot of wt and AAV2-~PLA2-His VNPs using a-His 
antibody. Positive signal is observed only for VP1 of ~P.His, demonstrating subunit 
specific insertion of the His5 tag. VP markers corresponding to different subunits is 
indicated left of blot. 
Temperature reactive properties of AA V2-i!PLA2-His capsid similar to wt. Next, we 
performed a dot blot assay to demonstrate the His6 tag is both internal to the capsid in 
the unactivated state and is properly externalized upon external stimulation, similarly to 
wt virus. AAV2-~PLA2-His and wtAAV were incubated at different temperatures for 30 
minutes, applied to a nitrocellulose membrane, and probed with various antibodies (Fig 
5.5). A20 detects intact AAV2 capsids and 81 detects a buried C-terminal epitope 
common to all 3 VPs that becomes exposed upon capsid denaturation. A69 detects an 
N-terminal epitope present in VP1 and VP2 that becomes exposed upon VNP activation 
(or denaturation), and a-His detects the His5 tag. 
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Figure 5.5. Dot blot of wt and AAV2-~PLA2-His (AP.His) VNPs after 30 minute 
exposure to various temperatures. A20 binds intact virus capsids, A69 binds N-
termini of VP1 and VP2, and 81 binds C-terminus of all three VPs (only accessible when 
capsid has been denatured). a-His binds to His6 tag. The blot demonstrates intact 
capsids at 37°, 60°, and 6S°C for both wt and L\P.His. N-termini externalization occurs at 
6S°C for both VNPs and His6 tag is evident only for L\P.His. Heating to ?soc results in 
capsid denaturation and all epitopes, except for A20, are accessible. 
At 37°C, both wtAAV and AAV2-L\PLA2-His VNPs are positive for A20 and negative for 
81, indicating capsids are intact. Importantly, no staining is evident for A69 or a-His for 
the mutant virus, indicating these residues are internal to the capsid. The capsid 
structure remains intact at 6S°C, but externalization of the N-termini is evident by the 
presence of positive A69 staining. Faint A69 and a-His staining are observed at 60°C in 
our AAV2-L\PLA2-His virus, representing the accepted temperature range of N-termini 
externalization. When exposed to 7S°C, both samples show a negative A20 staining and 
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a positive 81 staining, indicating the capsids are denatured. Lastly, utilizing an a-His 
antibody, we demonstrate that the His6 tag externalizes upon stimulation of AAV2-
f1PLA2-His at 65°C and that no His6 tag is present on wtAAV. Collectively, we have 
shown that insertion of the His6 tag does not appear to interfere with the supramolecular 
assembly of the capsid or modify its conformational change dynamics. The His6 tag is 
buried inside the VNP until it becomes externalized upon stimulation at approximately 
65°C. 
Heparin binding properties of AA V2-i!PLA2-His capsid similar to wt. An affinity 
assay was performed to determine if AAV2-f1PLA2-His maintained the wt ability to bind 
heparin (Fig. 5.6). WtAAV2 binds heparan sulfate proteoglycans as its natural receptor 
in humans.49• 92 Here, we are interested in modifying a specific functional output of the 
VNPs (e.g. externalization of active peptide domains) while maintaining all other virus 
features, such as binding properties of the capsid. Virus samples from either wt or 
AAV2-f1PLA2-His populations were added to a heparin-agarose affinity column. The 
column was subsequently washed with buffer containing increasing salt concentrations, 
and the concentration of virus genomes in each fraction was determined using QPCR. 
The elution profiles of the two virus samples are similar, sharing a characteristic peak 
elution at 500 mM NaCI. The result suggests that insertion of the His6 tag in the VP1 N-
terminus does not affect heparin binding properties of the VNP. 
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Figure 5.6. Heparin affinity assay demonstrates similar binding of wt and AAV2-
~PLA2-His VNPs. Both wt and AAV2-~PLA2-His (~P.His) VNPs display similar peak 
elutions at 500 mM NaCI. Results from one representative experiment are shown. 
AA V2-11PLA2-His binds nickel upon activation with heat. We next investigated the 
ability of AAV2-flPLA2-His to externalize His6 tags and bind nickel upon stimulation with 
heat. If successful , this would be the first proof-of-concept demonstration of 
reprogramming the dynamic externalization of functional motifs on the AAV capsid . 
AAV2-flPLA2-His and wt viruses were incubated at 60° or 65°C and then loaded onto 
nickel columns (Figure 5.7) . After washing and eluting with an imidazole buffer solution , 
virus genomic content in the collected fractions was analyzed using QPCR. When 
heated to 65°C, only 12°/o of wtAAV is recovered in the elution. In contrast, 
approximately 39°/o of the AAV2-ilPLA2-His viral load is recovered when the mutant is 
activated at 65°C. The 3.2-fold enhancement in recovery is statistically significant (p < 
0.005) . Activation at 60°C also increases the amount of AAV2-flPLA2-His recovered in 
the elution compared to wt, but the difference is not statistically significant. This result 
80 
corresponds well to our dot blot results (Figure 5. 7) , suggesting the His6 tags on the 
AAV2-f1PLA2-His VNPs are both externalized and functional at 65°C. 
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Figure 5.7. AAV2-.dPLA2-His VNP binds nickel upon activation with heat. AAV2-
~PLA2-His (~P . His) and wt VNPs were exposed to 60° and 65°C for 30 minutes, loaded 
onto Ni affinity spin columns, and eluted with an imidazole buffer. Activation of ~P . His at 
65°C results in significantly greater amount of VNP captured and eluted from the column, 
suggesting not only that the His6 tag is functional but also that this activity can occur at a 
range of temperatures. Amount of virus in elutions was determined by QPCR and data 
represent mean values (error bars represent standard error of the mean). Asterisk 
indicates p < 0.05 for comparison to all other groups. 
Optimal activation temperature exists for AA V2-i!PLA2-His binding nickel. We 
sought to further narrow down the optimal activation temperature for externalizing the 
His6 tags. We exposed the intact mutant virus to 37°, 60°, 63°, 65°, and 75°C prior to 
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loading onto nickel affinity columns (Figure S.8). Virus genomes in elution fractions were 
again quantified using QPCR. Compared to the 20°/o recovered with 60°C activation, 
exposing the viruses to 63°C increases the amount recovered to 44°/o. A similar 
improvement of VNP recovery was seen at 6S°C as well. These values are statistically 
significant when comparing the 63° and 6S°C groups to the other temperatures. The 
difference between 63° and 6S°C groups is not statistically significant. The control 
treatment of AAV2-f1PLA2-His at 37°C is not expected to yield high recovery since N-
terminus externalization does not occur at this temperature (Figure S.S). Furthermore, 
exposure of the virus to 7S°C fully denatures the capsid (Figure S.S) ; therefore the 
released virus genomes are expected to pass through the column during the loading and 
washing steps, resulting in little recovery in the elutions. Indeed, the expected outcomes 
for 37°C and 7S°C treatments are observed. 
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Figure 5.8. Binding of AAV2-~PLA2-His VNP to nickel is modulated by 
temperature. AAV2-~PLA2-His VNP was exposed to 37°, 60°, 63°, 6S 0 , and 75°C for 
30 minutes, loaded onto Ni affinity spin columns, and eluted with an imidazole buffer. 
AAV2-~PLA2-His stimulated at 63° or 6S°C yields the greatest binding to nickel. Virus 
capsid denatures at 7S°C and, therefore, elution is not above the 37°C control. Amount 
of VNP in elutions was determined by QPCR and data represent mean values (error 
bars represent standard error of the mean) . Asterisk indicates p < 0.05 for 63° and 6S°C 
samples in comparison to the 37°, 60°, and 7S°C groups. There was no statistically 
significant difference between the 63° and 6S°C groups. 
Verification of capsid properties after temperature activation and nickel binding. 
To confirm VNP integrity and interrogate capsid conformational status after elution from 
the nickel column, we performed dot blots on VNPs in the elution fractions. After heating 
VNP samples to 6S°C, we evaluated AAV2-ilPLA2-His and wt capsids both prior to 
column loading and after elution (Figure S.9). Appropriately, the wtAAV has strong A20 
(intact capsid) and there is no signal for the a-His antibody in the preload fraction. A 
weak A20 signal is present in the elution fraction. As 6S°C is close to the upper limit of 
capsid stability, we have a faint 81 signal in the wt sample. The AAV2-ilPLA2-His VNP 
83 
sample demonstrates that both the pre-load and the elution fraction demonstrate a 
strong positive signal for A20, and a-His. This result is expected and further supports 
the hypothesis that externalization of His6 tags upon heating confers metal-binding 
functionality to the AAV2-llPLA2-His VNPs. 
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Figure 5.9. AAV2-flPLA2-His VNP capsid remains intact after Ni column. AAV2-
~PLA2-His (~P.His) and wt VNPs were exposed to 65°C for 30 minutes, loaded onto Ni 
affinity spin columns, and eluted with an imidazole buffer. The preload VNPs and the 
elution fraction were evaluated using dot blot. A20 binds intact virus caps ids, B 1 binds 
C-terminus of all three VPs (only accessible when capsid has been denatured), and a-
His binds to His6 tag. The blot demonstrates intact capsids for both wt and llP.His (with 
minimal denaturing for wt preload) both before and after Ni column. The His6 tag is 
evident only for llP.His virus. 
5.5 Discussion 
To reprogram the functional output of the AAV capsid conformational change behavior, 
we replaced the PLA2 domain in the N-terminus of VP1 with a His5 tag. As 
demonstrated by Western blot (Figure 5.4), the His6 is appropriately expressed only on 
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VP1. The virus variant capsid successfully self-assembles similarly to wt, with N-termini 
inaccessible to antibodies at 37°C (Figure 5.5) . Furthermore, the temperature-induced 
conformational change behavior, predominantly characterized by the surface display of 
VP1 and VP2 N-termini, occurs under similar conditions between the mutant and wt 
VNPs. Specifically, incubating both VNPs at 65°C for 30 minutes results in N-termini 
externalization while maintaining the integrity of the intact capsid. These results, 
combined with the maintenance of heparin binding by the mutant (Figure 5.6) , strongly 
support our conclusion that we have only modified the functional output of the capsid 
conformational change, leaving capsid assembly, binding properties of the capsid 
exterior, and conformational change dynamics of the capsid unaltered. 
We next demonstrated that the inserted His6 tag is not only functional , but is externalized 
only upon external stimulation with heat. This was observed through immunoblotting 
and nickel affinity column assays (Figure 5.7 & 5.8). Upon activation at 63° or 65°C, His6 
tags previously internal to the VNP become surface-exposed and the VNP is able to bind 
nickel at levels significantly greater than before activation. This temperature range 
appears to yield maximum N-terminus externalization while maintaining capsid integrity. 
Additional studies are necessary to improve the amount of mutant virus bound and 
eluted from the nickel columns and decrease the amount of wt virus found in elution 
fractions. Optimizing imidazole concentrations in the wash and elution steps may help 
increase virus yield and differentiation. 
Theoretically, each AAV particle will only externalize five His6 tags, underscoring the 
importance of each binding event in holding the almost 4 MDa virus capsid in place 
during the column washing steps. Furthermore, a distribution of capsid subunit 
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stoichiometries per VNP likely exists, generating a subset of capsids with greater than 
five His6 tags per VNP and some with less. Recently, Koerber et al. and Zhang et al. 
inserted His6 tags into surface exposed regions on the AAV caps ids. 92· 93 These 
insertions resulted in the presentation of 50-60 nickel binding sites per VNP, leading to a 
substantial increase in virus binding to a nickel column. In our investigation, however, 
lower binding is not unexpected given the ten-fold lower number of potential binding 
motifs. Whether this lower binding efficiency is acceptable will be determined in future 
studies and will likely be dependent on the particular conferred functionality and ultimate 
application. Any potential reversibility of the N-termini externalization process would also 
decrease the number of His6 tags available for nickel binding. There is no evidence to 
suggest that this process is reversible, but further studies are required to conclusively 
answer this crucial question. 
5.6 Conclusions 
We present the first proof-of-concept demonstration that the functional output of the 
AAV-based VNP, in response to a specific external stimulus, can be reprogrammed. In 
particular, we exploited the intrinsic property of the VNP to dynamically externalize 
peptide domains upon stimulation with heat in order to create genetically encoded 
nanoparticles that possess the potential to bind a variety of metal ions (Ni , Cu, Zn , or Co) 
upon heat exposure. Utilizing AAV's unique ability to externalize a previously hidden 
protein domain is an innovative approach to designing supramolecular switches. 
Incorporation of other functional domains should enable the VNP to carry out more 
sophisticated tasks. 
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Furthermore, our studies have revealed insights into the process of VP1 N-terminus 
externalization. We demonstrated that the PLA2 domain is not required for N-terminus 
externalization. Additionally, since mutant VNPs with His5 tags can be isolated with 
nickel columns, the insertion location is sufficiently accessible for binding to external 
surfaces. 
Overall , the studies presented here lay the groundwork for developing intelligent, 
genetically encoded nanoparticles with novel functions. Further advancements to 
nanoparticle design will help broaden and strengthen the application of virus based 
nanoscale materials for human use. 
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CHAPTER SIX 
Directed evolution of adena-associated virus for modification of tropism 
and capsid dynamics 
6.1 Acknowledgements 
I would like to thank Kelly Horn for her contributions to preliminary EP-PCR 
troubleshooting and Chris Dempsey for running flow cytometry studies for serotype 
analysis. 
6.2 Introduction 
In Chapters 2-5 we have explored the use of AAV virus particles for non-conventional 
applications. We have shown that AAV can be efficiently immobilized for tissue 
engineering applications as well as for high-throughput microarray studies. We have 
also shown that the virus output of AAV can be altered for the presentation of alternative 
domains. However, for AAV to be most effective in these and other applications, the 
virus must be specific in either its tropism or stimuli that it detects. To address these 
needs, we are using directed evolution to create tailored AAV vectors with the efficiency 
and specificity required for our applications. 
AAV viral vectors are currently being tested in over 75 human clinical trials. The ultimate 
efficiency and success of in vivo gene delivery is highly dependent on effective virus 
localization and transduction efficiency. Bottlenecks to delivery include antibody 
neutralization and binding to and being processed in the target cells. To address these 
concerns, several directed evolution methods, including DNA shuffling ,32-34 error-prone 
88 
polymerase chain reaction (EP-PCR),27• 28 peptide display,29· 30 and transposon 
mutagenesis31 , have been used to optimize AAV gene delivery. Successful mutants 
have been found to evade serum neutralization, infect coronary artery cells, infect brain 
cells, and infect glioma cells, among other applications.29-36 
We are interested in using directed evolution to generate vectors for 2 applications: 1) 
improved transduction efficiency in target cells, and 2) altered activation temperature 
threshold. 
A promising new strategy for cancer treatment involves the delivery of apoptotic shRNA. 
For these strategies to be successful, we must have a vector capable of efficiently 
delivering these cassettes to cancer cells. In our lab, we are interested in targeting 
ovarian cancer cells. First, to determine the native efficacy of AAV serotypes on ovarian 
cancer cells, we tested the transduction efficiency of AAV1-9 and AAV12 on a panel of 
ovarian cancer cells, using an MOl of 1000 virus particles per cell (Figure 6.1 A-G). He La 
cells were used for comparison, as they are highly permissive to AAV2 infection. Very 
low levels of transduction are seen in most ovarian cancer cell types. To create viral 
vectors capable of delivering nucleic acids with high efficiency to ovarian cancer cells, 
we have decided to use directed evolution. This approach involves the generation of 
large, diverse virus libraries and the application of appropriate selection strategies to 
isolate improved variants. AAV2 transduces HeyA8 cells with at a modest 34°/o at this 
relatively low MOl. Because of this pre-existing level of transduction, we have selected 
these cells as the target cells for our selection strategy. It will be our first goal to isolate 
a pool of mutants with increased efficiency in transducing this cell line. 
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Figure 6.1. Transduction of ovarian cancer cell lines by ten AAV serotypes. 
(A)-(F) Ovarian cancer cells (and Hela cells as an AAV2 control) were infected with 
AAV serotypes at an MOl of 1000. (G) Ovarian cancer cells show very limited 
permissivity to AAV, as compared to Hela cells. Cells were fixed 72 h post infection and 
GFP expression was quantified with flow cytometry. 
In the second use of directed evolution, we are interested in modifying the activation 
temperature of AAV. In Chapter 5 we explored the use of AAV as a potential biosensor 
by modifying the N-terminus output upon temperature activation. As the ultimate goal of 
this work is to control the virus "input" and "output", it is crucial that we gain more 
information about the 'input' properties of the virus particles. Currently, response to heat 
is being investigated as a potential proof-of-concept input. We are developing libraries 
of mutant virus to isolate clones with modified temperature response profiles. As a first 
step, we are looking to isolate clones that externalize their N-terminal residues at 
temperatures lower than 60°C. In other words, we hope to identify less thermostable 
AA V variants. 
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The library creation process is similar for both applications. First, we used the wild-type 
AAV2 cap as a template for mutagenesis (Figure 6.2). DNA was mutagenized using an 
EP-PCR procedure and cloned into a cap-free vector to reform the virus genome.28 
Libraries were generated using Taq polymerase, MgCb. an unbalanced dNTP ratio, and 
MnCI2. Taq polymerase is reported to have an error rate of 2.4x1 o-4 mutations per base 
for each amplification cycle. 94 Taq's natural bias for AT to GC mutations will be 
mitigated using an unbalanced dNTP ratio including a lower concentration of dATP and 
dGTP relative to dTTP and dCTP.95 An increased concentration of MgCI2 further 
facilitates error incorporation by stabilizing non-complementary base pair binding.96 
Increased concentrations of MnCb lead to an increased occurrence of point mutations, 
due to the interaction of Mn2+ with DNA.97 Re-ligated vectors were transformed into and 
propagated in E.Coli. DNA was isolated from these cells and transfected (along with 
helper plasmids) into 293T packaging cells. Virus mutants will be isolated and selection 
strategies will be applied. Potential mutants of interest will be studied via QPCR, 
western blot, and sequencing. Mutant DNA can then be subcloned into the original 
vector to create new virus libraries to be further enriched through additional rounds of 
selection. 
(1) Isolation of cap gene 
(2) Random mutagenesis 
through EP-PCR 
(3) Re-clone genome to Q;.c;:~~~ 
form plasmid library Q-fiiiii:~=~ 
(6) Analyze mutants, 
re-clone for repeated 
mutagenesis or selection 
(5) Select for mutants with 
desired properties 
(4) Package and purify 
virus library 
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Figure 6.2. Overview of directed evolution procedure. AAV cap genes are isolated, 
mutagenized, and cloned into the remaining AAV2 genome to create mutant vectors. 
These plasmids are used to package virus in HEK 293T cells. Virus particles are 
harvested, purified, and applied to a selection strategy. Successful mutants are isolated 
and characterized, then subjected to additional mutagenesis and selection. 
Our first library, AAV2-EP, will be used to isolate virus mutants with increased 
transduction efficiency in ovarian cancer cells. Diversity in this library has been 
confirmed and the final error rate is 2/1 OOObp of cap gene, or approximately 5 errors per 
cap gene. Preliminary selection studies have been conducted to begin isolating mutants 
with increased gene delivery efficiency. 
Our ~PLA-His externalization library (~P.His-EP) is based on the AAV-~PLA-His 
construct developed in Chapter 5. A virus library with 2.8/1 OOObp of cap gene, or 
approximately 7 errors per cap gene has been generated based on AAV-~PLA-His. 
Initial selection schemes involve the isolation of mutants with temperature responsive 
properties that are slightly different from the wild-type virus. In particular, we are 
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isolating pools of mutants that are capable of N-terminus externalization at a sub-optimal 
temperature (58°C). Nickei-NTA columns used in Chapter 5 have been used to capture 
mutants with this capability. After further enrichment, amino acid changes in these 
mutants will be studied in order to draw conclusions about the mechanism for N-terminus 
externalization, as this phenomenon is very poorly understood.23· 24· 98 Once we have a 
better understanding of this dynamic property of the virus, we can begin to engineer 
alternative inputs. These novel stimuli may be small molecules or proteins present in a 
sample of interest. 
6.3 Materials and Methods 
Cell transduction assays. Ovarian cancer cells were cultured at 37 oc with C02. 277 4 
cells (cultured in MEM supplemented with 5o/o FBS, 1 x L-glutamine, 1 x Sodium 
Pyruvate, 1 x MEM-NEAA, and 1 Ofc> penicillin/streptomycin), A2780 (RPMI1640 
supplemented with 15°/o FBS and 1 Ofc> penicillin/streptomycin), HeyAB (RPMI1640 
supplemented with 15°/o FBS and 1 Ofc> penicillin/streptomycin), IGROV-AF1 (RPMI1640 
supplemented with 1 0°/o FBS and 1 °/o penicillin/streptomycin), and SKOV-3 (DMEM 
supplemented with 1 0°/o FBS and 1 °/o penicillin/streptomycin) were tested for their 
permissivity to ten AAV serotypes. Hela cells (cultured in DMEM with 1 0°/o FBS and 
1 °/o penicillin/streptomycin) were used as a positive control for AAV2 transduction. Cells 
were passed to 24 well plates and transduced the next day at a confluency of ..... 75-80°/o. 
Cells were transduced with AAV1-9 and AAV12 at an MOl of 1000. Cells were 
harvested 72 hours post infection, were fixed with 4°/o PFA-PBS, and added to FACS 
tubes with cap filters. Samples were performed in triplicate using a FACSCantoll 
(Becton Dickinson, Franklin Lakes, NJ), with 1 e4 cells analyzed for each sample. 
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Error-prone PCR. pSub201 and AAV2-~PLA2-His were used as templates for EP-PCR. 
Primer C (5'-GCGGAAGCTTCGATCAACTACGF-3') and Primer K (5 '-
GGGACTAGTAATTACAGATTACGAGTCAGGTATCTGGTG-3') were used to amply the 
cap sequence from the 5'- and 3'- end and introduce Hindi II and Spel sites, respectively. 
Primers were used at a concentration of 50 11M. Reaction conditions were used as those 
by Koerber et al. 28 Mutagenic buffer (70mM MgCb, 500 mM KCI , 100 mM Tris {pH 8.3) , 
0.1 °/o (wt/vol) gelatin) and Taq polymerase (NEB, lpswitch, MA) were used to introduce 
mutations. An unbalanced 10X dNTP mix (2mM dATP, 2 mM dGTP, 10 mM dCTP, 10 
mM dTTP, Invitrogen) was also used. Final reaction conditions were: mutagenic buffer (5 
IJI) , 5 mM MnCI2 {1 .5 IJI) , 1 OX dNTP mix (5 Ill) , 50 11M Primer C (1 Ill) , 50 11M Primer K (1 
Ill) , template DNA (1 0 ng/IJI, 1 Ill) , Taq polymerase (5U/1JI , 1 Ill) , and ultrapure water 
(34.5 111). Samples were amplified by 24 rounds of PCR. 
Vector creation. Plasmid vector pSub2SpeiStuff, a variation of that used by Koerber, 
et al28, was used to create mutant virus libraries. This cap-free vector contains the virus 
ITRs and rep with adjacent restriction enzymes to directionally clone in the mutant cap 
genes. A Spel restriction site was introduced instead of a Notl site. Between Hindlll and 
Spel restriction sites, a 1 OOObp non-coding region of the LacZ gene was introduced to 
confirm vector digestion. 
Plasmid library creation. Amplified cap genes were isolated on 1 °/o agarose gels. The 
approximately 2.6kb bands were purified using a Zymo Gel Extraction kit (Irvine, CA) . 
Samples were digested for 1 hour at 37°C using Hindi II and Spel (NEB) and run on 0.8°/o 
agarose gel. Modified cap genes were cloned into pSub2SpeiStuff at a 1 :3 ratio using 
T4 DNA polymerase (NEB). For each ligation, 100 ng of vector plasmid was used and 
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samples were ligated at room temperature for 1 h. Samples were purified into 10 ~I 
water using a Zymo Clean and Concentrate kit. The full volume was then transformed 
into electrocompetent DH5a E.Coli cells (-1 e9 cfu/1 ug). Samples were allowed to 
recover 20 minutes and were plated onto LB plates containing ampicillin. To determine 
library diversity, 1 ~L of the library was placed on a plate and colonies were counted the 
next day. Plasmid was harvested using a Zymo Miniprep kit or an Invitrogen Purelink 
Maxi prep kit. 
Sequence verification. Clones were selected from each library for sequencing. Ten 
plasmid clones were sequenced using a primer upstream of the AAV2 heparin binding 
domain. Sequencing was performed by Lone Star Labs (Houston, TX). Sequences 
were aligned to the wt AAV2 sequence using VectorNTI 10 software (Invitrogen). 
Virus library production. Virus was produced as describe by Koerber et al. 28 293T 
cells were used to produce virus and were transfected using polyethyleneimine (PEl). 
Cells were transfected with 7 ng library plasmid, 25 ~g pBiuescript (stuffer plasmid to 
ensure that each cell only receives one library plasmid), and 25 ~g pXX6. Cells were 
harvested 72 h post transfection and purified as in Chapters 2 and 3. 
Western blot verification. Virus production was further verified using western blotting. 
Blots were performed on virus samples as in Chapter 5. ~P.His-EP samples were 
probed with both 81 and anti-His6 antibodies. AAV2-EP samples were probed with 81. 
Virus library sequence verification. Virus library diversity was determined by 
sequencing ten virus mutants. Purified virus samples were lysed using heat and NaOH 
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treatment. Sequences were amplified using PCR and Primers C and K. Mutant cap 
genes were subcloned into pSub2SpeiStuff and transformed into electrocompetent 
DHSa cells. Ten clones were miniprepped, sequenced , and analyzed as above. 
Virus selection on target cells. The AAV2-EP library was used for selection on HeyA8 
ovarian cancer cells. Cells were seeded onto a 10 em tissue culture dish. The next day, 
cells were transduced at a density of 75°/o. AAV2-EP was added at an MOl of 1000 and 
AdS was added at an MOl of 20. Cells were harvested 48 hours post infection, 
resuspended in buffer, and lysed using three cycles of freeze/thaw. Samples titers were 
quantified using QPCR. Mutant virus was re-applied using decreasing MOis. 
i!P.His dot blot. Virus samples were diluted 1:40 and heat treated for 30 minutes at 
either 37, 58, 60, 63, 65, 70, or 75 oc. Dot blots were performed as in Chapter 5. 
Nickel column selection. ~P.His-EP library samples were activated at 58°C for 30 
minutes and applied to a nickel spin column as in Chapter 5. Fractions were collected 
and virus concentrations were quantified using QPCR with primers against the rep gene. 
Virus cap genes were amplified using Primer C and Primer K and cloned back into 
pSub2SpeiStuff. Virus libraries were then created as listed earlier. 
6.4 Results 
Effect of MnCI2 on AA V2 cap gene error rate. It is difficult to predict the amount of 
error that we must introduce to create virus mutants with our desired properties. In order 
to create the diversity that we need, it might be necessary to test libraries with varying 
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levels of mutations. Error rates can be modified by a number of factors. Polymerases 
can have variations in their native error rates, adding varying amounts of diversity. In 
these studies, we have used Taq polymerase, which has a native error rate of ,....3 errors 
per 10,000 bp. However, by adding additional co-factors such as MnCb, we are able to 
further increase the error rate of our mutant product. We have shown that by using a 
constant concentration of Taq polymerase and template DNA we are capable of 
drastically altering the error rate of our product simply by modifying the amount of MnCb 
added to our amplification reaction (Figure 6.3). This regulation of error rate will allow us 
to potentially modulate the conservative nature of our library. Too many errors can 
possibly lead to destabilization concerns, while too few errors may not give us the 
change in virus properties needed to achieve our goals. If the initial libraries do not yield 
our desired results, we can create additional libraries using more or less conservative 
amplification strategies, yielding lower or higher error rates. If we have introduced too 
much diversity and the capsid is destabilized , it would be possible to create libraries with 
lower levels of mutations. However, if virus particles are too close to wild-type and their 
phenotype has not been sufficiently altered, we can use more MnCb to introduce higher 
levels of diversity. 
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Figure 6.3. Effect of MnCI2 on cap gene error rate. Increasing the concentration of 
MnCb increases the observed error rate on the AAV2 cap gene. 
Creation and verification of AA V2-EP virus libraries. Error-prone PCR libraries were 
created using Taq polymerase and MnCb. Mutant cap genes were purified on an 
agarose gel and cloned into a cap-tree vector containing the remainder of the AAV2 
genome. AAV2-EP (EP-PCR library based on wild-type AAV2 cap gene) plasmid library 
diversity was estimated at 1 e6 library members (Table 6.1 ). After sequencing isolated 
clones, the error rate of the plasmid library was determined to be '""'2.6errors/1 OOObp. 
The transition rate was determined to be 42°/o, while there were 58°/o transversions. 
There were no insertions or deletions, which is important as these could cause gene 
truncation and inhibit capsid formation . 
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1 bl 6 1 AAV2 EP PI a e - "d L"b asm1 1 rarv A naiYSIS 
Transitions 42°/o 
Transversions 58°/o 
Insertions/deletions QOfo 
Error rate 2.6bp/1 OOObp 
Diversity 1e6 
AAV2-EP virus libraries were created by transfecting 293T cells with 7 ng libray DNA per 
15 em tissue culture dish. Cells were co-transfected with helper plasmid pXX6 and 
pBiuescript. Plasmid pBiuescript was used as a filler to help ensure that only one library 
member would enter each cell. Multiple cap sequences in one cell could lead to mosaic 
capsids, since the supramolecular structure of the virus self-assembles. Virus titer was 
determined to be 1.57e11 vg/ml, a reasonable titer as most are in the range of 1 e11-
1 e12 vg/ml (Table 6.2) . 
1 bl 6 2 AAV2 EP v· L"b A a e . - 1rus 1 rarv naiVSIS 
Transitions 64°/o 
Transversions 36°/o 
Insertions/deletions 0°/o 
Error rate 2bp/1000bp 
Titer 1.57e11 vQ/ml 
AAV2-EP virus library error rate was determined to be 2bp/1 OOObp, slightly less than that 
of the plasmid library. This is reasonable as variants with higher error rates might be 
less likely to form viable capsids. In contrast to the plasmid library, the virus library had 
64°/o transitions and 36°/o transversions, a shift towards more transitions. There were no 
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observed insertions or deletions, as these mutations would be expected to yield 
incomplete capsids. 
Western blot analysis shows that the appropriate virus subunit sizes and ratios are 
maintained in the virus library (Figure 6.4). As compared to wt AAV2, AAV2-EP has the 
same VP1 , VP2, and VP3 subunit sizes (87, 72, and 62 kDa, respectively). The 
characteristic stoichiometic 1 :1 :10 virus subunit ratio is also preserved. 
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Figure 6.4. Western blot of wt AAV2 and AAV2-EP. Similar band sizes and 
stoichiometric ratios are observed when wt AAV2 and AAV2-EP are probed with 81 
antibody, indicating that no significant change in virus capsid structure has occurred. 
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Selection of mutants with increased HeyAB transduction efficiency. Our first 
selection goal is to isolate an AA V2 mutant with increased capacity to transduce HeyAB 
ovarian cancer cells for shRNA therapy. We applied our AAV2-EP virus library to cells at 
an MOl of 1 000. Cells were co-infected with adenovirus at an MOl of 20, as adenovirus 
is required for the replication of AAV. After 48 h, cells were scraped and resuspended in 
buffer. After three cycles of freeze-thaw to lyse the cells, cell debris was spun down and 
viral content in the supernatant was quantified using QPCR. This pool of mutant virus 
was applied to cells for the next round of selection. Overall, five rounds of selection 
were performed with decreasing MOis (Figure 6.5) . 
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Figure 6.5. Mutant virus recovery over five rounds of selection. AAV2-EP was 
applied to HeyAB cells at decreasing MOis. Virus was co-infected with adenovirus to 
allow for replication. Virus titers were quantified after each round using QPCR. 
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Analysis of isolated virus pool. After five rounds of selection, virus cap genes were 
isolated by lysing the viral capsids. Genes were amplified using primers outside of the 
mutant cap genes and sublconed into the previously used pSub2Spelstuff vector for 
sequencing and virus production. Mutant pool transduction efficiency was directly 
compared to that of the wild-type by conducting a side-by-side transduction analysis. 
HeyA8 cells were either infected with wild-type AAV2 or our enriched pool at an MOl of 
1000. Cells were co-infected with adenovirus at an MOl of 20. Cells were lysed 48 h 
post-infection and viral content was quantified using QPCR (Table 6.3). The enriched 
pool yields a 8700% increase in recovery over the wild-type virus. To analyze clones in 
this enriched pool, ten sequences were analyzed to determine mutations in the 
successful clones (Table 6.3). However, no clones tested yielded similar mutations. 
This suggests that we may not have found the "fittest" mutant in our pool. Additional, 
tighter selection conditions might help isolate the most successful clones. 
"J; bl 6 3 H AS 5 I t d L"b A a e . ey, eec e 1 rary naiYSIS 
Increase over wt -8700% 
Transitions 86% 
Transversions 14% 
Insertions/deletions 0% 
Error rate 1 .4bp/1 OOObp 
Response of capsids to temperature change. In addition to modifying virus particles 
for altered tropism, we aim to modify the virus conformational dynamics of the virus. 
Specifically, we are creating libraries to isolate mutant vectors capable of externalizing 
their N-termini at slightly lower than optimal temperatures. By analyzing mutations that 
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led to these changes, we hope to determine relevant residues that can be altered to 
allow the virus capsids to respond to additional stimuli. 
We first determined the effect of temperature on wt AAV-Iike capsid conformation. 
~P.His virus was exposed to temperatures ranging from 37-75°C and stained with A20 
(intact capsids), A 1 (N-terminus externalization), and 81 (disassembled virus subunits) 
(Figure 6.6A). At 37°C, a strong A20 signal is observed, indicating almost all virus is 
intact. A small amount of 81 signal is observed, indicating that a subset is denatured. 
When heated to 58°C, we begin to see a small amount of A 1 signal, indicating the 
beginning of the N-terminus externalization processes. Stronger A 1 signaling is 
observed from 60°C-65°C. When heated from 70°C-75°C, capsid disassociation is 
complete, with strong A 1 and 81 signaling observed. 
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Figure 6.6. Dot blot of ~P.His. (A) ~P . His virus was exposed to temperatures ranging 
from 37-75°C and probed with A20, A1 , and 81 antibodies. (B) The density values for 
each antibody signal were determined. The A20/A 1 ratio was plotted as a measure of 
capsid stability. A 1 was plotted as a measure of N-terminus externalization. 
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Density values for each spot were also determined using FluorChem software (Figure 
6.68). Normalized A 1 signal was plotted for each temperature, further highlighting the 
gradual increase in N-terminus externalization that occurs around 60°C. The A20/B1 
ratio was also plotted to demonstrate the degradation of capsid integrity that occurs as 
the supramolecular structure is exposed to heat. N-terminus externalization, without 
significant denaturation of the capsid, occurs in the 60-65°C region. 
Creation and verification of A.P.His-EP virus libraries. Error-prone PCR libraries 
were created using Taq polymerase and MnCI2. Mutant b.P.His cap genes were purified 
on an agarose gel and cloned into a cap-free vector containing the remainder of the 
AAV2 genome. Plasmid library diversity was estimated at 9e5 library members (Table 
6.4). After analyzing selected clones, the error rate of the plasmid library was 
determined to be -5.8 errors/1 OOObp. The transition rate was determined to be 48%, 
while there were 52% transversions. As seen with our AAV2-EP library, there were no 
insertions or deletions. 
T< bl 6 4~RH" EP PI a e . . IS "d L"b asm1 1 rarv A naiVSIS 
Transitions 48% 
Transversions 52% 
Insertions/deletions 0% 
Error rate 5.8bo/1 OOOb~: 
Diversity 9e5 
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~P.His-EP (EP-PCR library based on ~PLA-His mutant) virus libraries were created by 
transfecting 293T cells with 7 ng libray DNA per 15 em tissue culture dish. Cells were 
co-transfected with helper plasmid pXX6 and pBiuescript. Virus titer was determined to 
be 5.6e11 vg/mL, a reasonable titer as most are in the range of 1 e11-1 e12 vg/mL (Table 
6.5). 
"r bl 6 5 ~P.H" EP v· a e . . IS 1rus L"b 1 rarv A naiVSIS 
Transitions 64% 
Transversions 36% 
Insertions/deletions 0% 
Error rate 2.8bp/1 OOObp 
Titer 5.56e11 vq/ml 
~P.His-EP virus library error rates were determined to be 2.8/1000bp, a 48% decrease 
from what is observed in the plasmid library. A reduction in error rates for the virus 
library compared to the plasmid library was also observed with AAV2-EP. In contrast to 
the plasmid library, the virus library had 64% transitions and 36% transversions, a shift 
towards more transitions. There were no observed insertions or deletions, as these 
mutations would be expected to yield incomplete capsids. 
Western blot analysis shows that the appropriate virus subunit sizes and ratios are 
maintained (Figure 6.7). As compared to wt AAV2 and ~P.His, ~P.His-EP has the 
same, shorter VP1 subunit size as ~P.His, due to the replacement of the PLA2 domain 
with the shorter hexahistidine tag (Figure 6. 7 A). The VP2 and VP3 subunits are the 
same size, as expected. The characteristic stoichiometic 1 :1 :10 virus subunit ratio is 
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also preserved. Presence of a band in the a-His blot (Figure 6.78) for ~P. His and 
~P.His-EP represent successful His tag insertion. 
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Figure 6.7. Western blot of wtAAV2, ~P.His, and ~P.His-EP. Denaturing western 
blot of virus samples was probed with 81 (A) or a-His (B). Decreased band size and the 
presence of His tag in ~P.His-EP are as expected. 
Temperature selection of i1P.His-EP library. To select for mutants externalizing N-
terminus residues at lower temperatures, we performed a nickel column isolation as in 
Chapter 5. ~p. His-EP samples were activated at 58°C and applied to a nickel spin 
column. Load, wash , and three elution fractions were collected and virus concentration 
was quantified using QPCR (Figure 6.8) . Elution fractions were pooled, capsids lysed, 
and the contained genomes amplified and subcloned in order to create a new pool of 
virus mutants. 
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Figure 6.8. Temperature selection of ~P.His-EP. LlP.His-EP was exposed to 58°C 
and run through a nickel affinity spin column. Elution fractions were pooled and cap 
DNA from successful clones was isolated and subcloned to form a new library of 
selected virus. A modest increase in recovery is observed, but this level does not reach 
that of 63°C activation. 
When activated at 58°C, we observe a 3°/o recovery with the LlP.His-EP library. After 
one round of selection, we re-applied this selected virus pool to the column. When 
elution fraction were pooled, we observe a 14°/o recovery of viral genomes within these 
fractions. This modest increase in recovery suggests the isolation of potentially 
favorable mutations that allow for the externalization of the AAV2 N-terminus at a slightly 
suboptimal temperature. This recovery is still dramatically lower than that observed at 
the 63°C optimal temperature determined in Chapter 5. Additional rounds of selection 
and mutagenesis could potentially enrich this population, leading to the isolation of one 
or more mutants capable of increased activity at 58°C. 
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6.5 Conclusions 
Directed evolution holds the potential to create and isolate AAV2 mutants capable of 
improved functionalities. Many studies have been conducted to modify viral tropism for a 
range of in vivo applications. Isolated mutants have shown improved capability to 
increase transduction efficiency as well as antibody avoidance. In Chapters 2-5, we 
have used AAV for surface-immobilized gene delivery and biosensing applications. For 
these platform technologies to be successful, it is necessary to control the properties of 
the virus. To address this goal, we have created mutant libraries based on the wild-type 
AAV2 genome, as well as our b.P.His mutant virus. Initial studies indicate that we have 
created diverse, functional libraries of AAV2 variants. Our preliminary selection 
strategies suggest that we can isolate pools of mutants with increased functionality. 
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CHAPTER SEVEN 
Conclusions and future directions 
7.1 Conclusions 
In this thesis we have demonstrated that AAV2 can be surface-immobilized and 
successfully localized while maintaining the integrity of the capsid structure. Successful 
virus patterning through both microcontact printing and robotic spotting allowed for 
reverse transduction of HeLa cells. Additionally, we have modified the output of AAV2 
by replacing an enzymatic domain necessary for infection with a nickel binding 
hexahistidine tag. Through these methods we have harnessed the function of AAV2 for 
novel applications. Optimization through directed evolution could further the efficacy of 
these platforms. 
7.2 Future directions 
Microcontact printing. In Chapter 2, we have demonstrated successful patterning of 
AAV2 for substrate mediated gene delivery by using PDMS stamps and alkanethiol 
SAMs to localize adhesive protein (HFN) and recombinant AAV. While we are able to 
demonstrate successful gene expression on these surfaces, we were able to test the 
versatility of our platform by introducing additional adhesive proteins in Chapter 3. 
Collagen I, laminin, elastin, and PLL were all capable of facilitating successful HeLa cell 
localization and AAV2 gene delivery. The dramatic increase in gene expression 
observed on laminin surfaces was an interesting result from this study. We 
hypothesized that this increase in gene expression could be due to 1) increased He La 
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cell transcriptional activity on laminin surfaces or 2) favorable binding interactions 
between AAV2 and laminin. Since BrU incorporation suggests that Hela cells are not 
more transcriptionally active when seeded onto laminin coated surfaces, we are 
exploring additional methods to study AAV-adhesive protein interactions. 
Using the platform developed in Chapters 2 and 3, there is a wealth of information still to 
be generated. First, the protein-AAV interaction information we are developing can be 
used for in vitro virus vector patterning and tissue engineering. As various cell types 
may require different adhesive proteins for cellular attachment, we may need to further 
explore the interaction of additional proteins and AAV. Also, there are 11 other naturally 
occurring AAV serotypes that we have not explored. These serotypes, because they 
display different amino acids on their capsids, may have completely different adhesive 
protein binding profiles. As each serotype has different tropism properties, it may be 
advantageous to use these vectors in our in vitro constructs to increase efficiency in 
different target cells. 
One potential method to study the interaction between AAV and ECM proteins is quartz 
crystal microbalance with dissipation (QCM-D). We have begun promising preliminary 
studies to investigate virus-protein interactions. We are using gold-coated quartz 
sensors to perform these studies, a setup that is very similar to the microcontact printing 
done in Chapters 2 and 3. These coverslips are functionalized by the addition of 2mM 
-CH3 terminated alkanethiol for 1 h. Samples are rinsed with ethanol and dried with N2. 
Using a Q-Sense E4 (Sweden), we are able to observe a frequency shift corresponding 
to AAV deposition on the SAM as well as AAV deposition directly onto pre-adsorbed 
HFN (Figure 7.1 ). Additional experiments can be conducted using other adhesive 
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proteins, and the amount of AAV adsorbed can be quantified using the Sauerbrey 
equation , which relates change in frequency to mass. 
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Figure 7 .1. QCM analysis of AAV deposition. Using -CH3 functionalized sensors, we 
are able to detect the deposition of AAV onto surfaces directly (top) or onto surfaces pre-
adsorbed with HFN (bottom). 
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If more information is determined about specific serotype-adhesive protein interactions, 
this knowledge could potentially translate to improved in vivo gene therapy. While it is 
known that certain serotypes target different cell types within the human body, little is 
known about the actual mechanism of targeting. It is widely believed that targeting is 
primarily due to the interaction of capsid residues with ligands on the outside of cells or 
possibly intracellular processing of the virus. 10 However, an additional dimension to the 
story could be that the interaction of AAV with ECM proteins can critically impact what 
cells are positively transduced. This mechanism appears plausible, as it has previously 
been shown that co-injection with heparin allows AAV2 to diffuse farther in vivo. 65 
Co-injection with an ECM protein that a virus vector has high affinity for could essentially 
"block" the virus from non-specific adsorption to ECM within the body, allowing the virus 
to travel further. Since we observe that the interaction of AAV and adhesive proteins 
does not appear to restrict transduction (the virus is able to desorb from the protein 
layer), this may not negatively affect the transduction efficiency of the virus once it nears 
the target cell type. Transduction will still be successful as long as the AAV-cell 
interaction is stronger than the AAV-ECM interaction. Additionally, once this 
phenomenon is better understood, it could be possible to modify virus vectors to display 
desired ECM binding properties. Residues responsible for this interaction could be 
removed through site-directed mutagenesis in order to block these interactions and allow 
for increased circulation. If the ECM-virus interaction is desired, it may be possible to 
increase this interaction, or add this property to mutants isolated through directed 
evolution. 
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For in vitro patterned gene delivery to be most effective for tissue engineering, we will 
likely need to control the localization of different AAV vectors delivering different 
recombinant DNA cassettes. Currently, we are capable of only localizing virus with a 
single transgene, but there are a number of ways that this technology could be furthered. 
First, it may be possible to use laser-scanning lithography (LSL) to successively desorb 
protein resistant alkanethiols and sequentially add adhesive proteins and virus vectors to 
create more complex 2D patterns.99 We have begun preliminary testing with AAV2 to 
determine if this platform is compatible with virus deposition (Figure 7.2). In this sample, 
a gold coverslip was functionalized with an -OEG terminated protein resistant 
alkanethiol. Using LSL, nine small areas were desorbed, leaving behind a bare gold 
layer. HFN and virus were sequentially applied to the sample. When Hela cells were 
added, they were localized to eight of the desorbed locations. Both successful cell 
adhesion and gene expression are observed. 
Figure 7 .2. LSL patterning of AAV2. Gold-coated coverslips were functionalized with 
-OEG terminated alkanethiol and desorbed in a nine spot pattern. Samples were 
incubated with HFN followed by AAV2. Samples were seeded with Hela cells and 
imaged for GFP expression at 72 h. (Experiment conducted with Dr. John Slater.) 
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One bottleneck to this technique is possible deposition of subsequent virus onto 
previously adsorbed spots. This will disrupt the localization of gene delivery, causing 
some areas to be transduced by multiple virus vectors. There are a number of possible 
solutions that can be explored to remedy this problem. First, a variety of blocking agents 
(BSA, StabiiGuard) at different concentrations could be added to the sample between 
patterning steps, to prevent non-specific adhesion of new protein. Second, wash steps 
with low levels of salt could be used to disrupt protein-protein interactions. However, 
caution must be taken not to disassemble the capsid structure of the virus, or remove 
virus bound to the underlying adhesive protein. 
Finally, LSL could be used to pattern different alkanethiols, each with a terminal group 
specific to a corresponding AAV mutant. Collections of binding pairs could be used to 
link the SAM to AAV particles in solution (Figure 7.3). Binding domains could be surface 
exposed on the AAV capsid, allowing specific virus mutants to bind to these alkanethiols. 
Now, instead of protein being added after each desorption step, a specified alkanethiol 
could be added. When patterning is complete, a pool of virus vectors could be added, 
each localizing to its corresponding SAM binding pair. 
Functionalization of coverslip with 
-OEG terminated alkanethiol 
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Figure 7 .3. LSL using capsid-specific alkanethiols. Using LSL, it may be possible to 
sequentially desorb an -OEG terminated alkanethiol and backfill with alkanethiol 
solutions forming capsid-specific SAMs. When patterning is completed, a pool of virus 
vectors could be added, with vectors self-aligning to the corresponding SAM. 
Live cell genetic microarrays using AA V. In Chapter 4, we used AA V and a robotic 
spotter to create localized islands of transduced cells. We have tested several substrate 
conditions to isolate a coating that leads to localized expression. Also, we have 
determined an optimal virus concentration range for efficient gene expression. To 
further this technology, there are several steps that could be taken. First, cell island 
formation could potentially be optimized using different pin geometries to create circular 
cell islands, in contrast to the linear islands we observe with the pin used in these 
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studies. Also, it should be possible to deposit different combinations of different virus 
vectors, allowing for high-throughput gene expression studies. 
To make our platform more versatile, a number of alterations could be explored. As the 
goal is to use this platform for high-throughput studies, multiple virus vectors could be 
patterned by relatively simple robot programming. Virus samples are placed in 384 well 
plates, and the robotic arm can be moved to the location of different wells. To simply 
deposit multiple virus vectors in one spot, deposition could be done over multiple rounds. 
One vector could be patterned, then the arm could return to the supply wells, take up 
another sample, and deposit that onto the previous spot. Alignment would be preserved 
as the slide, arm, and well plate would not be moved in between steps. 
This system could incorporate different ECM proteins, as these are known to be 
important in cellular differentiation. As with patterning multiple virus vectors, virus and 
ECM protein combinations could be patterned by using multiple rounds of spotting. 
Previous microarray technologies have shown the importance of testing ECM 
components in a combinatorial fashion to determine their effects on target cells. 100 
Combining ECM proteins with gene delivery vectors would allow for an even more 
complex combinatorial analysis. 
One interesting application of our platform would be the study of cellular co-cultures. 
Within the stem cell niche, supporting cells are also critical to stem cell maintenance and 
differentiation. 16 Analyzing co-cultures, gene delivery, and ECM effects in a high-
throughput manner would allow for a quick, efficient method for analyzing many 
variables. Additional complexity could be achieved by using virus vectors capable of 
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targeting only one cell type within the co-culture, thus restricting gene delivery to that cell 
type. This system could be used to mimic potential changes in supporting cells and their 
effects on stem cells. 
AA V2 as a biosensor. In Chapter 5, we began to explore AA V2 as a biosensor by 
replacing the wild-type output with a hexahistidine tag. Activated virus particles could be 
isolated using a nickel affinity column. Preliminary evidence suggests that virus can be 
patterned using our robotic spotter platform and then activated (Figure 7.4) . These 
results should be verified to ensure proper function of the virus when immobilized to a 
nitrocellulose coated substrate. While we have discussed these biosensors in the 
context of immobilization onto a substrate, it is possible for these biosensors to be used 
intracellularly. As the primary function of AAV is cellular infection, this type of sensing 
could be uniquely appropriate for this biosensor. 
Figure 7.4. Deposition and activation of ~P.His virus on 3 mg/ml nitrocellulose. 
Virus was deposited, activated at 63°C, and immunostained using an anti-His antibody 
and AF532-conjugated secondary antibody. Three virus spots are shown. 
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While our proof-of-concept studies have set the groundwork for using AAV2 as a 
biosensor, additional modifications must be explored to evolve these particles into useful 
sensors. This would involve alterations of both the input and output functionalities of the 
virus nanoparticles. Current "inputs" of the virus include temperature treatment and 
intracellular processing. To modify these inputs for a desired stimulus, perhaps a 
specific biomolecule or target protein, we must make modifications to the dynamic 
response. Future work to create these changes will likely rest in the further exploration 
of our directed evolution libraries (Chapter 6), isolating residues crucial in this process. 
Appropriate VNP outputs is another avenue that must be addressed to use AAV as a 
biosensor. Interesting domains could be those that induce viral aggregation or produce 
a light or color response. Current studies in our lab are exploring the use of leucine 
zipper domains as a replacement for the PLA2 domain. It is hypothesized that upon 
activation, these domains would externalize, interact, and allow the virus to aggregate. 
An alternative to this strategy would be the use of biomolecular fluorescence 
complementation, where a portion of a fluorescent protein (GFP, for example) would be 
inserted into the N-terminus. Full GFP protein could not be used in this instance, as the 
insertion of this protein in the AAV2 N-terminus leads to surface exposed GFP. 101 Upon 
activation, these fragments would be externalized and capable of interacting with the 
complementing fragment externalized by another virus particle, producing a fluorescent 
response. 
Directed evolution of AA V. In Chapters 2-5 we explored the use of AAV for substrate 
mediated gene delivery and biosensing. Optimal performance of the virus in these 
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applications might depend on altering the capsid properties. We have created virus 
libraries and verified both sequence diversity and correct protein subunit size. 
While we have shown successful virus function using wild-type AA V2, it may be 
necessary in the future to modify the transduction profiles of the virus to target a cell type 
with increased efficiency. Depending on the application, AAV2 (or another naturally 
occurring serotype) may not be sufficient for gene delivery. The libraries developed in 
this work, or similar libraries modified with higher error rates, could be used to select for 
clones with increased efficiency. We have also been working to develop additional 
libraries based on peptide display29 and DNA shuffling.32 
Peptide display involves the insertion of a random peptide domain into a specific region 
of the virus. For AAV2, we have targeted the heparin binding domain as this is a surface 
exposed, tropism conferring domain. We are developing libraries that display random 
seven amino acid motifs within this region. This combination of rational (based on 
insertion location) and combinatorial (large libraries of random insertions) offers a 
potentially effective method for altering tropism. The development of DNA shuffling 
libraries is based on recombination of virus cap DNA for two or more of the twelve 
naturally occurring serotypes. As each serotype has different properties, this method 
allows for the recombination of these domains with the hope of creating new, functional 
vectors. 
Mutations generated through EP-PCR could be used to identify residues responsible for 
various functionalities of the virus. For example, Maheshri et al used EP-PCR to identify 
residues responsible for antibody neutralization.27 For our work, this method could be a 
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powerful way to identify residues that are responsible for the adhesive protein binding 
explored in Chapters 2 and 3. One potential selection strategy could be to incubate virus 
libraries with an adhesive protein, allow virus particles to bind, and then analyze the cap 
DNA of capsids that did not bind. Common mutations could be analyzed to determine 
any potential trends. 
Similar to using EP-PCR to identify residues involved in antibody binding, interesting 
information could potentially be gained from exploring our .D.P.His-EP libraries. Very little 
is known about the N-terminus externalization process for AAV2. Specifically, we do not 
know which domains are important for allowing these residues to externalize when 
exposed to stimuli. By creating random mutations and selecting for clones that have 
altered function, we may be able to correlate these protein residues to specific functions. 
This mapping could be the first step towards modifying AAV2 for an in vitro biosensor 
capable of responding to a novel stimulus. 
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